| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC12A6 CACNA1C GPR89B CACNA1D CACNA1F CACNA1S SPNS1 SCN11A SLC5A10 TRPC7 HTR3A ATP13A1 SLC38A9 SLC35B3 SLC24A3 GRIK1 GRIK2 SLC7A7 MCOLN1 SLC9C2 SLC1A4 RYR2 SLC5A1 LRRC52 TPCN1 SLC5A3 ITPR3 SLC5A11 SLC6A2 ABCG1 KCNQ5 SLC44A5 SLC10A5 SCN1A GJD3 SCN2A SLC22A4 SCN3A SCN7A SCN8A KCNK10 KCNK2 ABCD3 SLC9A7 GPR89A TRPV3 LRRC8B SLC38A11 HTR3B SLC5A8 ATP12A SLC51A SLC12A7 ATP2B2 SLC33A1 ATP2B4 | 2.52e-29 | 1180 | 157 | 56 | GO:0022857 |
| GeneOntologyMolecularFunction | transporter activity | PITPNM2 SLC12A6 CACNA1C GPR89B CACNA1D CACNA1F CACNA1S SPNS1 SCN11A SLC5A10 TRPC7 HTR3A ATP13A1 SLC38A9 SLC35B3 SLC24A3 GRIK1 GRIK2 SLC7A7 MCOLN1 SLC9C2 SLC1A4 RYR2 SLC5A1 LRRC52 TPCN1 SLC5A3 ITPR3 SLC5A11 SLC6A2 ABCG1 KCNQ5 SLC44A5 SLC10A5 SCN1A GJD3 SCN2A SLC22A4 SCN3A SCN7A SCN8A KCNK10 KCNK2 ABCD3 SLC9A7 GPR89A TRPV3 LRRC8B SLC38A11 HTR3B SLC5A8 ATP12A SLC51A SLC12A7 ATP2B2 LMBRD1 SLC33A1 ATP2B4 | 2.98e-29 | 1289 | 157 | 58 | GO:0005215 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | SLC12A6 CACNA1C CACNA1D CACNA1F CACNA1S SCN11A SLC5A10 TRPC7 ATP13A1 SLC24A3 GRIK1 GRIK2 MCOLN1 SLC9C2 RYR2 SLC5A1 LRRC52 TPCN1 SLC5A3 ITPR3 SLC5A11 SLC6A2 KCNQ5 SLC10A5 SCN1A SCN2A SCN3A SCN7A SCN8A KCNK10 KCNK2 SLC9A7 TRPV3 SLC5A8 ATP12A SLC12A7 ATP2B2 ATP2B4 | 6.35e-28 | 465 | 157 | 38 | GO:0046873 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | SLC12A6 CACNA1C GPR89B CACNA1D CACNA1F CACNA1S SCN11A SLC5A10 TRPC7 HTR3A ATP13A1 SLC24A3 GRIK1 GRIK2 MCOLN1 SLC9C2 SLC1A4 RYR2 SLC5A1 LRRC52 TPCN1 SLC5A3 ITPR3 SLC5A11 SLC6A2 KCNQ5 SLC10A5 SCN1A GJD3 SCN2A SCN3A SCN7A SCN8A KCNK10 KCNK2 SLC9A7 GPR89A TRPV3 LRRC8B HTR3B SLC5A8 ATP12A SLC12A7 ATP2B2 ATP2B4 | 1.97e-26 | 793 | 157 | 45 | GO:0015075 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | SLC12A6 CACNA1C CACNA1D CACNA1F CACNA1S SCN11A SLC5A10 TRPC7 HTR3A ATP13A1 SLC24A3 GRIK1 GRIK2 MCOLN1 SLC9C2 RYR2 SLC5A1 LRRC52 TPCN1 SLC5A3 ITPR3 SLC5A11 SLC6A2 KCNQ5 SLC10A5 SCN1A SCN2A SCN3A SCN7A SCN8A KCNK10 KCNK2 SLC9A7 TRPV3 HTR3B SLC5A8 ATP12A SLC12A7 ATP2B2 ATP2B4 | 2.24e-24 | 664 | 157 | 40 | GO:0008324 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | SLC12A6 CACNA1C CACNA1D CACNA1F CACNA1S SCN11A SLC5A10 TRPC7 ATP13A1 SLC24A3 GRIK1 GRIK2 MCOLN1 SLC9C2 RYR2 SLC5A1 LRRC52 TPCN1 SLC5A3 ITPR3 SLC5A11 SLC6A2 KCNQ5 SLC10A5 SCN1A SCN2A SCN3A SCN7A SCN8A KCNK10 KCNK2 SLC9A7 TRPV3 SLC5A8 ATP12A SLC12A7 ATP2B2 ATP2B4 | 3.12e-23 | 627 | 157 | 38 | GO:0022890 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | SLC12A6 CACNA1C CACNA1D CACNA1F CACNA1S SCN11A SLC5A10 TRPC7 ATP13A1 SLC24A3 GRIK1 GRIK2 MCOLN1 SLC9C2 SLC1A4 RYR2 SLC5A1 LRRC52 TPCN1 SLC5A3 ITPR3 SLC5A11 SLC6A2 KCNQ5 SLC10A5 SCN1A SCN2A SCN3A SCN7A SCN8A KCNK10 KCNK2 SLC9A7 TRPV3 SLC5A8 ATP12A SLC12A7 ATP2B2 ATP2B4 | 2.69e-21 | 758 | 157 | 39 | GO:0015318 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | SLC12A6 CACNA1C GPR89B CACNA1D CACNA1F CACNA1S SCN11A TRPC7 HTR3A SLC24A3 GRIK1 GRIK2 MCOLN1 SLC1A4 RYR2 LRRC52 TPCN1 ITPR3 KCNQ5 SCN1A GJD3 SCN2A SCN3A SCN7A SCN8A KCNK10 KCNK2 GPR89A TRPV3 LRRC8B HTR3B SLC5A8 SLC12A7 | 1.23e-20 | 526 | 157 | 33 | GO:0022803 |
| GeneOntologyMolecularFunction | channel activity | SLC12A6 CACNA1C GPR89B CACNA1D CACNA1F CACNA1S SCN11A TRPC7 HTR3A SLC24A3 GRIK1 GRIK2 MCOLN1 SLC1A4 RYR2 LRRC52 TPCN1 ITPR3 KCNQ5 SCN1A GJD3 SCN2A SCN3A SCN7A SCN8A KCNK10 KCNK2 GPR89A TRPV3 LRRC8B HTR3B SLC12A7 | 1.21e-19 | 525 | 157 | 32 | GO:0015267 |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | SCN11A SLC5A10 SLC24A3 GRIK1 GRIK2 MCOLN1 SLC9C2 SLC5A1 TPCN1 SLC5A3 SLC5A11 SLC6A2 SLC10A5 SCN1A SCN2A SCN3A SCN7A SCN8A SLC9A7 SLC5A8 ATP12A | 2.54e-19 | 171 | 157 | 21 | GO:0015081 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | CACNA1C GPR89B CACNA1D CACNA1F CACNA1S SCN11A TRPC7 HTR3A SLC24A3 GRIK1 GRIK2 MCOLN1 SLC1A4 RYR2 LRRC52 TPCN1 ITPR3 KCNQ5 SCN1A GJD3 SCN2A SCN3A SCN7A SCN8A KCNK10 KCNK2 GPR89A TRPV3 LRRC8B HTR3B | 2.74e-19 | 459 | 157 | 30 | GO:0005216 |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | CACNA1C CACNA1D CACNA1F CACNA1S SCN11A TRPC7 HTR3A SLC24A3 GRIK1 GRIK2 MCOLN1 RYR2 LRRC52 TPCN1 ITPR3 KCNQ5 SCN1A SCN2A SCN3A SCN7A SCN8A KCNK10 KCNK2 TRPV3 HTR3B | 2.72e-17 | 343 | 157 | 25 | GO:0005261 |
| GeneOntologyMolecularFunction | gated channel activity | CACNA1C GPR89B CACNA1D CACNA1F CACNA1S HTR3A GRIK1 GRIK2 MCOLN1 RYR2 LRRC52 TPCN1 ITPR3 KCNQ5 SCN1A SCN2A SCN7A KCNK10 KCNK2 GPR89A HTR3B | 2.10e-13 | 334 | 157 | 21 | GO:0022836 |
| GeneOntologyMolecularFunction | sodium channel activity | SCN11A GRIK1 GRIK2 MCOLN1 TPCN1 SCN1A SCN2A SCN3A SCN7A SCN8A | 8.06e-12 | 52 | 157 | 10 | GO:0005272 |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | CACNA1C CACNA1D CACNA1F CACNA1S TRPC7 SLC24A3 GRIK1 MCOLN1 RYR2 TPCN1 ITPR3 TRPV3 ATP2B2 ATP2B4 | 1.50e-11 | 151 | 157 | 14 | GO:0015085 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC12A6 SLC5A10 ATP13A1 SLC35B3 SLC24A3 SLC9C2 SLC1A4 SLC5A1 SLC5A3 SLC5A11 SLC6A2 ABCG1 SLC44A5 SLC10A5 SLC22A4 ABCD3 SLC9A7 SLC5A8 ATP12A SLC12A7 ATP2B2 ATP2B4 | 2.55e-11 | 477 | 157 | 22 | GO:0022804 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | OR51A4 OR51A2 OR5B3 OR5T3 ERBB4 HTR3A OR5B2 OR5D14 OR10J3 OR5AN1 OR5T2 OR5A1 GRIK1 GRIK2 OR8U3 OR11H12 CHRM2 OR1D2 GPR83 OR52I2 OR5J2 CD247 TAS2R14 ADGRG2 FCGR3A FCGR3B SCN7A SORCS3 CCR1 CCR3 CCR6 OR10J4 HTR3B OR11H2 OR4C5 GABBR1 | 6.69e-11 | 1353 | 157 | 36 | GO:0004888 |
| GeneOntologyMolecularFunction | calcium channel activity | CACNA1C CACNA1D CACNA1F CACNA1S TRPC7 SLC24A3 GRIK1 MCOLN1 RYR2 TPCN1 ITPR3 TRPV3 | 4.33e-10 | 129 | 157 | 12 | GO:0005262 |
| GeneOntologyMolecularFunction | potassium ion transmembrane transporter activity | SLC12A6 SLC24A3 GRIK1 GRIK2 MCOLN1 SLC9C2 LRRC52 KCNQ5 KCNK10 KCNK2 SLC9A7 ATP12A SLC12A7 | 7.33e-10 | 167 | 157 | 13 | GO:0015079 |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 9.42e-10 | 26 | 157 | 7 | GO:0005248 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR51A4 OR51A2 OR5B3 OR5T3 OR5B2 OR5D14 OR10J3 OR5AN1 OR5T2 OR5A1 OR8U3 OR11H12 CHRM2 OR1D2 GPR83 OR52I2 OR5J2 TAS2R14 ADGRG2 SORCS3 CCR1 CCR3 CCR6 OR10J4 OR11H2 OR4C5 GABBR1 | 1.30e-09 | 884 | 157 | 27 | GO:0004930 |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC12A6 SLC5A10 SLC35B3 SLC24A3 SLC9C2 SLC1A4 SLC5A1 SLC5A3 SLC5A11 SLC6A2 SLC44A5 SLC10A5 SLC22A4 SLC9A7 SLC5A8 SLC12A7 | 1.64e-09 | 296 | 157 | 16 | GO:0015291 |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | SLC12A6 SLC5A10 ATP13A1 SLC24A3 SLC9C2 SLC5A1 SLC5A3 SLC5A11 SLC6A2 SLC10A5 SLC9A7 SLC5A8 ATP12A SLC12A7 ATP2B2 ATP2B4 | 2.09e-09 | 301 | 157 | 16 | GO:0022853 |
| GeneOntologyMolecularFunction | voltage-gated channel activity | CACNA1C GPR89B CACNA1D CACNA1F CACNA1S LRRC52 TPCN1 KCNQ5 SCN1A SCN2A KCNK10 KCNK2 GPR89A | 2.41e-09 | 184 | 157 | 13 | GO:0022832 |
| GeneOntologyMolecularFunction | symporter activity | SLC12A6 SLC5A10 SLC24A3 SLC1A4 SLC5A1 SLC5A3 SLC5A11 SLC6A2 SLC10A5 SLC22A4 SLC5A8 SLC12A7 | 2.48e-09 | 150 | 157 | 12 | GO:0015293 |
| GeneOntologyMolecularFunction | odorant binding | OR5B3 OR5T3 OR5B2 OR5D14 OR10J3 OR5AN1 OR5T2 OR5A1 OR8U3 OR5J2 OR10J4 | 5.07e-09 | 127 | 157 | 11 | GO:0005549 |
| GeneOntologyMolecularFunction | olfactory receptor activity | OR51A4 OR51A2 OR5B3 OR5T3 OR5B2 OR5D14 OR10J3 OR5AN1 OR5T2 OR5A1 OR8U3 OR11H12 OR1D2 OR52I2 OR5J2 OR10J4 OR11H2 OR4C5 | 8.85e-09 | 431 | 157 | 18 | GO:0004984 |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | CACNA1C GPR89B CACNA1D CACNA1F CACNA1S LRRC52 KCNQ5 SCN1A SCN2A KCNK10 KCNK2 GPR89A | 2.21e-08 | 182 | 157 | 12 | GO:0005244 |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 7.63e-08 | 70 | 157 | 8 | GO:1901618 | |
| GeneOntologyMolecularFunction | D-glucose:sodium symporter activity | 1.26e-07 | 7 | 157 | 4 | GO:0005412 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | SLC12A6 SLC5A10 SLC5A1 SLC5A3 SLC5A11 SLC6A2 SLC10A5 SLC5A8 SLC12A7 | 4.22e-07 | 119 | 157 | 9 | GO:0015294 |
| GeneOntologyMolecularFunction | myo-inositol transmembrane transporter activity | 1.90e-06 | 4 | 157 | 3 | GO:0005365 | |
| GeneOntologyMolecularFunction | sodium ion binding | 3.46e-06 | 14 | 157 | 4 | GO:0031402 | |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 3.46e-06 | 14 | 157 | 4 | GO:0008331 | |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 3.47e-06 | 81 | 157 | 7 | GO:0015370 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | SLC38A9 SLC35B3 GRIK1 GRIK2 SLC7A7 SLC1A4 SLC10A5 ABCD3 SLC38A11 SLC5A8 SLC51A SLC33A1 | 3.65e-06 | 293 | 157 | 12 | GO:0008514 |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 4.06e-06 | 31 | 157 | 5 | GO:0099604 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | SLC38A9 GRIK1 GRIK2 SLC7A7 SLC1A4 SLC10A5 ABCD3 SLC38A11 SLC5A8 SLC51A | 5.75e-06 | 207 | 157 | 10 | GO:0046943 |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | SLC38A9 GRIK1 GRIK2 SLC7A7 SLC1A4 SLC10A5 ABCD3 SLC38A11 SLC5A8 SLC51A | 6.00e-06 | 208 | 157 | 10 | GO:0005342 |
| GeneOntologyMolecularFunction | carbohydrate:monoatomic cation symporter activity | 8.08e-06 | 17 | 157 | 4 | GO:0005402 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 1.03e-05 | 18 | 157 | 4 | GO:0015278 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 1.52e-05 | 140 | 157 | 8 | GO:0099094 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 1.94e-05 | 105 | 157 | 7 | GO:0015171 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 2.62e-05 | 151 | 157 | 8 | GO:0008509 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 2.75e-05 | 152 | 157 | 8 | GO:0022843 | |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 2.76e-05 | 75 | 157 | 6 | GO:0098960 | |
| GeneOntologyMolecularFunction | hexose transmembrane transporter activity | 4.09e-05 | 25 | 157 | 4 | GO:0015149 | |
| GeneOntologyMolecularFunction | D-glucose transmembrane transporter activity | 4.09e-05 | 25 | 157 | 4 | GO:0055056 | |
| GeneOntologyMolecularFunction | alkali metal ion binding | 4.80e-05 | 26 | 157 | 4 | GO:0031420 | |
| GeneOntologyMolecularFunction | organic cation transmembrane transporter activity | 4.92e-05 | 83 | 157 | 6 | GO:0015101 | |
| GeneOntologyMolecularFunction | monosaccharide transmembrane transporter activity | 5.61e-05 | 27 | 157 | 4 | GO:0015145 | |
| GeneOntologyMolecularFunction | myo-inositol:sodium symporter activity | 6.14e-05 | 2 | 157 | 2 | GO:0005367 | |
| GeneOntologyMolecularFunction | fucose transmembrane transporter activity | 6.14e-05 | 2 | 157 | 2 | GO:0015150 | |
| GeneOntologyMolecularFunction | pentose transmembrane transporter activity | 6.14e-05 | 2 | 157 | 2 | GO:0015146 | |
| GeneOntologyMolecularFunction | potassium channel activity | 6.93e-05 | 128 | 157 | 7 | GO:0005267 | |
| GeneOntologyMolecularFunction | sugar transmembrane transporter activity | 7.49e-05 | 29 | 157 | 4 | GO:0051119 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 1.09e-04 | 60 | 157 | 5 | GO:0099529 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 1.26e-04 | 33 | 157 | 4 | GO:0005217 | |
| GeneOntologyMolecularFunction | polyol transmembrane transporter activity | 1.29e-04 | 13 | 157 | 3 | GO:0015166 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 1.39e-04 | 100 | 157 | 6 | GO:0030594 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 1.48e-04 | 193 | 157 | 8 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 1.70e-04 | 197 | 157 | 8 | GO:0022834 | |
| GeneOntologyMolecularFunction | P-type transmembrane transporter activity | 1.78e-04 | 36 | 157 | 4 | GO:0140358 | |
| GeneOntologyMolecularFunction | P-type ion transporter activity | 1.78e-04 | 36 | 157 | 4 | GO:0015662 | |
| GeneOntologyMolecularFunction | intracellularly phosphatidylinositol-3,5-bisphosphate-gated monatomic cation channel activity | 1.83e-04 | 3 | 157 | 2 | GO:0097682 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 2.23e-04 | 109 | 157 | 6 | GO:0042626 | |
| GeneOntologyMolecularFunction | L-amino acid transmembrane transporter activity | 2.42e-04 | 71 | 157 | 5 | GO:0015179 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 2.75e-04 | 73 | 157 | 5 | GO:0170055 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 2.99e-04 | 17 | 157 | 3 | GO:0099508 | |
| GeneOntologyMolecularFunction | carbohydrate transmembrane transporter activity | 3.26e-04 | 42 | 157 | 4 | GO:0015144 | |
| GeneOntologyMolecularFunction | ligand-gated sodium channel activity | 3.57e-04 | 18 | 157 | 3 | GO:0015280 | |
| GeneOntologyMolecularFunction | excitatory extracellular ligand-gated monoatomic ion channel activity | 3.58e-04 | 43 | 157 | 4 | GO:0005231 | |
| GeneOntologyMolecularFunction | low-affinity IgG receptor activity | 3.65e-04 | 4 | 157 | 2 | GO:0019772 | |
| GeneOntologyMolecularFunction | solute:potassium antiporter activity | 4.21e-04 | 19 | 157 | 3 | GO:0022821 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 4.64e-04 | 46 | 157 | 4 | GO:0005245 | |
| GeneOntologyMolecularFunction | NAADP-sensitive calcium-release channel activity | 6.05e-04 | 5 | 157 | 2 | GO:0072345 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in cardiac muscle cell action potential | 6.05e-04 | 5 | 157 | 2 | GO:0086007 | |
| GeneOntologyMolecularFunction | serotonin-gated monoatomic cation channel activity | 6.05e-04 | 5 | 157 | 2 | GO:0022850 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 7.24e-04 | 90 | 157 | 5 | GO:0008028 | |
| GeneOntologyMolecularFunction | alpha-tubulin binding | 7.42e-04 | 52 | 157 | 4 | GO:0043014 | |
| GeneOntologyMolecularFunction | C-C chemokine receptor activity | 7.52e-04 | 23 | 157 | 3 | GO:0016493 | |
| GeneOntologyMolecularFunction | chloride:monoatomic cation symporter activity | 7.52e-04 | 23 | 157 | 3 | GO:0015377 | |
| GeneOntologyMolecularFunction | C-C chemokine binding | 8.55e-04 | 24 | 157 | 3 | GO:0019957 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 8.55e-04 | 24 | 157 | 3 | GO:0099507 | |
| GeneOntologyMolecularFunction | kainate selective glutamate receptor activity | 9.03e-04 | 6 | 157 | 2 | GO:0015277 | |
| GeneOntologyMolecularFunction | IgE receptor activity | 9.03e-04 | 6 | 157 | 2 | GO:0019767 | |
| GeneOntologyMolecularFunction | serotonin receptor activity | 9.03e-04 | 6 | 157 | 2 | GO:0099589 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 1.05e-03 | 57 | 157 | 4 | GO:1904315 | |
| GeneOntologyMolecularFunction | monoatomic anion:monoatomic cation symporter activity | 1.09e-03 | 26 | 157 | 3 | GO:0015296 | |
| GeneOntologyMolecularFunction | G protein-coupled chemoattractant receptor activity | 1.09e-03 | 26 | 157 | 3 | GO:0001637 | |
| GeneOntologyMolecularFunction | chemokine receptor activity | 1.09e-03 | 26 | 157 | 3 | GO:0004950 | |
| GeneOntologyMolecularFunction | extracellularly glutamate-gated ion channel activity | 1.26e-03 | 7 | 157 | 2 | GO:0005234 | |
| GeneOntologyMolecularFunction | IgE binding | 1.26e-03 | 7 | 157 | 2 | GO:0019863 | |
| GeneOntologyMolecularFunction | IgG receptor activity | 1.26e-03 | 7 | 157 | 2 | GO:0019770 | |
| GeneOntologyMolecularFunction | monoatomic anion channel activity | 1.33e-03 | 103 | 157 | 5 | GO:0005253 | |
| GeneOntologyMolecularFunction | ATPase-coupled monoatomic cation transmembrane transporter activity | 1.44e-03 | 62 | 157 | 4 | GO:0019829 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 1.72e-03 | 65 | 157 | 4 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 1.72e-03 | 65 | 157 | 4 | GO:0022824 | |
| GeneOntologyMolecularFunction | potassium:chloride symporter activity | 2.13e-03 | 9 | 157 | 2 | GO:0015379 | |
| GeneOntologyMolecularFunction | L-glutamine transmembrane transporter activity | 2.13e-03 | 9 | 157 | 2 | GO:0015186 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | SLC12A6 CACNA1C GPR89B CACNA1D CACNA1F CACNA1S SCN11A SLC5A10 TRPC7 HTR3A ATP13A1 SLC24A3 GRIK1 GRIK2 MCOLN1 SLC9C2 SLC1A4 RYR2 SLC5A1 LRRC52 TPCN1 SLC5A3 ITPR3 SLC5A11 SLC6A2 KCNQ5 SLC10A5 SCN1A GJD3 SCN2A SLC22A4 SCN3A SCN7A SCN8A KCNK10 KCNK2 SLC9A7 GPR89A CCR1 TRPV3 LRRC8B SARAF SLC38A11 HTR3B SLC5A8 ATP12A SLC12A7 ATP2B2 ATP2B4 | 1.73e-20 | 1374 | 158 | 49 | GO:0006811 |
| GeneOntologyBiologicalProcess | metal ion transport | SLC12A6 CACNA1C CACNA1D CACNA1F CACNA1S SCN11A SLC5A10 TRPC7 ATP13A1 SLC24A3 GRIK1 MCOLN1 SLC9C2 RYR2 SLC5A1 LRRC52 TPCN1 SLC5A3 ITPR3 SLC5A11 SLC6A2 KCNQ5 SLC10A5 SCN1A SCN2A SLC22A4 SCN3A SCN7A SCN8A KCNK10 KCNK2 SLC9A7 CCR1 TRPV3 SARAF SLC38A11 SLC5A8 ATP12A SLC12A7 ATP2B2 ATP2B4 | 3.49e-19 | 1000 | 158 | 41 | GO:0030001 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | SLC12A6 CACNA1C GPR89B CACNA1D CACNA1F CACNA1S SCN11A SLC5A10 TRPC7 HTR3A ATP13A1 SLC24A3 GRIK1 GRIK2 MCOLN1 SLC9C2 SLC1A4 RYR2 SLC5A1 LRRC52 TPCN1 SLC5A3 ITPR3 SLC6A2 KCNQ5 SCN1A GJD3 SCN2A SCN3A SCN7A SCN8A KCNK10 KCNK2 SLC9A7 GPR89A TRPV3 LRRC8B HTR3B ATP12A SLC12A7 ATP2B2 ATP2B4 | 2.59e-18 | 1115 | 158 | 42 | GO:0034220 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | SLC12A6 CACNA1C CACNA1D CACNA1F CACNA1S SCN11A SLC5A10 TRPC7 ATP13A1 SLC24A3 GRIK1 MCOLN1 SLC9C2 RYR2 SLC5A1 LRRC52 TPCN1 SLC5A3 ITPR3 SLC5A11 SLC6A2 KCNQ5 SLC10A5 SCN1A SCN2A SLC22A4 SCN3A SCN7A SCN8A KCNK10 KCNK2 SLC9A7 CCR1 TRPV3 SARAF SLC38A11 HTR3B SLC5A8 ATP12A SLC12A7 ATP2B2 ATP2B4 | 9.87e-18 | 1157 | 158 | 42 | GO:0006812 |
| GeneOntologyBiologicalProcess | sodium ion transport | SCN11A SLC5A10 SLC24A3 GRIK1 MCOLN1 SLC9C2 SLC5A1 TPCN1 SLC5A3 SLC5A11 SLC6A2 SLC10A5 SCN1A SCN2A SLC22A4 SCN3A SCN7A SCN8A SLC9A7 SLC38A11 SLC5A8 ATP12A ATP2B4 | 1.59e-17 | 275 | 158 | 23 | GO:0006814 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | SLC12A6 CACNA1C CACNA1D CACNA1F CACNA1S SCN11A SLC5A10 TRPC7 HTR3A ATP13A1 SLC24A3 GRIK1 MCOLN1 SLC9C2 SLC1A4 RYR2 SLC5A1 LRRC52 TPCN1 SLC5A3 ITPR3 SLC6A2 KCNQ5 SCN1A SCN2A SCN3A SCN7A SCN8A KCNK10 KCNK2 SLC9A7 TRPV3 HTR3B SLC5A8 ATP12A SLC12A7 ATP2B2 ATP2B4 | 1.95e-16 | 1017 | 158 | 38 | GO:0098660 |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | SLC12A6 CACNA1C CACNA1D CACNA1F CACNA1S SCN11A SLC5A10 TRPC7 HTR3A ATP13A1 SLC24A3 GRIK1 MCOLN1 SLC9C2 RYR2 SLC5A1 LRRC52 TPCN1 SLC5A3 ITPR3 SLC6A2 KCNQ5 SCN1A SCN2A SCN3A SCN7A SCN8A KCNK10 KCNK2 SLC9A7 TRPV3 HTR3B ATP12A SLC12A7 ATP2B2 ATP2B4 | 3.62e-16 | 922 | 158 | 36 | GO:0098662 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | SLC12A6 CACNA1C CACNA1D CACNA1F CACNA1S SCN11A SLC5A10 TRPC7 ATP13A1 SLC24A3 GRIK1 MCOLN1 SLC9C2 RYR2 SLC5A1 LRRC52 TPCN1 SLC5A3 ITPR3 SLC6A2 KCNQ5 SCN1A SCN2A SCN3A SCN7A SCN8A KCNK10 KCNK2 SLC9A7 TRPV3 HTR3B ATP12A SLC12A7 ATP2B2 ATP2B4 | 4.49e-15 | 942 | 158 | 35 | GO:0098655 |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | SCN11A SLC5A10 SLC24A3 GRIK1 MCOLN1 SLC9C2 SLC5A1 TPCN1 SLC5A3 SLC6A2 SCN1A SCN2A SCN3A SCN7A SCN8A SLC9A7 ATP12A ATP2B4 | 3.45e-14 | 208 | 158 | 18 | GO:0035725 |
| GeneOntologyBiologicalProcess | import across plasma membrane | SLC12A6 CACNA1C CACNA1D CACNA1F CACNA1S SLC9C2 SLC1A4 SLC5A1 SLC5A3 ACSL1 SLC22A4 SLC9A7 TRPV3 LRRC8B ATP12A SLC12A7 ATP2B4 | 2.41e-12 | 230 | 158 | 17 | GO:0098739 |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR51A4 OR51A2 CACNA1F OR5B3 OR5T3 SCN11A OR5B2 OR5D14 OR10J3 OR5AN1 OR5T2 OR5A1 GRIK2 OR8U3 OR11H12 OR1D2 OR52I2 OR5J2 TAS2R14 SCN1A OR10J4 OR11H2 ATP2B2 OR4C5 | 1.79e-11 | 582 | 158 | 24 | GO:0050906 |
| GeneOntologyBiologicalProcess | intracellular chemical homeostasis | SLC12A6 CACNA1C GPR89B CACNA1D CACNA1F CACNA1S SPNS1 PDE3B TRPC7 ATP13A1 WNT7B RTN4 SLC24A3 GRIK2 MCOLN1 SLC9C2 RYR2 ITPR3 ABCG1 EFHC1 HPS1 SCN7A SLC9A7 GPR89A CCR1 ATP12A SLC12A7 ATP2B2 ATP2B4 | 1.79e-11 | 866 | 158 | 29 | GO:0055082 |
| GeneOntologyBiologicalProcess | cellular homeostasis | SLC12A6 CACNA1C GPR89B CACNA1D CACNA1F CACNA1S SPNS1 PDE3B TRPC7 ATP13A1 WNT7B RTN4 SLC24A3 GRIK2 MCOLN1 SLC9C2 RYR2 ITPR3 SLC6A2 ABCG1 EFHC1 HPS1 SCN7A SLC9A7 GPR89A CCR1 ATP12A SLC12A7 ATP2B2 ATP2B4 | 7.09e-11 | 981 | 158 | 30 | GO:0019725 |
| GeneOntologyBiologicalProcess | sensory perception | OR51A4 OR51A2 CACNA1D CACNA1F OR5B3 OR5T3 SCN11A OR5B2 OR5D14 OR10J3 OR5AN1 OR5T2 OR5A1 GRIK2 OR8U3 OR11H12 ITPR3 OR1D2 OR52I2 OR5J2 SERPINB6 TAS2R14 SCN1A HPS1 SCN8A OR10J4 PPIP5K2 OR11H2 CFAP69 ATP2B2 OR4C5 | 1.30e-10 | 1072 | 158 | 31 | GO:0007600 |
| GeneOntologyBiologicalProcess | detection of stimulus | OR51A4 OR51A2 CACNA1F OR5B3 OR5T3 SCN11A OR5B2 OR5D14 OR10J3 OR5AN1 OR5T2 OR5A1 GRIK2 OR8U3 OR11H12 RYR2 OR1D2 OR52I2 OR5J2 TAS2R14 SCN1A OR10J4 OR11H2 ATP2B2 OR4C5 | 2.65e-10 | 722 | 158 | 25 | GO:0051606 |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | OR51A4 OR51A2 CACNA1D OR5B3 OR5T3 SCN11A PDE3B OR5B2 OR5D14 OR10J3 OR5AN1 OR5T2 OR5A1 OR8U3 LMBRD2 OR11H12 CHRM2 ITPR3 OR1D2 GPR83 OR52I2 OR5J2 TAS2R14 ADGRG2 KCNK2 SORCS3 CCR1 C3 CCR3 CCR6 OR10J4 OR11H2 ATP2B4 OR4C5 GABBR1 | 3.23e-10 | 1395 | 158 | 35 | GO:0007186 |
| GeneOntologyBiologicalProcess | monoatomic cation homeostasis | SLC12A6 CACNA1C GPR89B CACNA1F CACNA1S SPNS1 TRPC7 ATP13A1 SLC24A3 GRIK2 MCOLN1 SLC9C2 RYR2 ITPR3 EFHC1 HPS1 SCN7A SLC9A7 GPR89A CCR1 ATP12A SLC12A7 ATP2B2 ATP2B4 | 8.81e-10 | 705 | 158 | 24 | GO:0055080 |
| GeneOntologyBiologicalProcess | inorganic ion import across plasma membrane | SLC12A6 CACNA1C CACNA1D CACNA1F CACNA1S SLC9C2 SLC5A1 SLC9A7 TRPV3 ATP12A SLC12A7 ATP2B4 | 9.90e-10 | 142 | 158 | 12 | GO:0099587 |
| GeneOntologyBiologicalProcess | inorganic cation import across plasma membrane | SLC12A6 CACNA1C CACNA1D CACNA1F CACNA1S SLC9C2 SLC5A1 SLC9A7 TRPV3 ATP12A SLC12A7 ATP2B4 | 9.90e-10 | 142 | 158 | 12 | GO:0098659 |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 1.04e-09 | 62 | 158 | 9 | GO:0086002 | |
| GeneOntologyBiologicalProcess | monoatomic ion homeostasis | SLC12A6 CACNA1C GPR89B CACNA1F CACNA1S SPNS1 TRPC7 ATP13A1 SLC24A3 GRIK2 MCOLN1 SLC9C2 RYR2 ITPR3 EFHC1 HPS1 SCN7A SLC9A7 GPR89A CCR1 ATP12A SLC12A7 ATP2B2 ATP2B4 | 1.23e-09 | 717 | 158 | 24 | GO:0050801 |
| GeneOntologyBiologicalProcess | chemical homeostasis | SLC12A6 CACNA1C GPR89B CACNA1D CACNA1F CACNA1S SPNS1 ERBB4 PDE3B TRPC7 ATP13A1 WNT7B RTN4 SLC24A3 GRIK2 MCOLN1 SLC9C2 RYR2 ITPR3 ABCG1 EFHC1 HPS1 SCN7A SLC9A7 GPR89A CYP7B1 CCR1 HAS2 ATP12A SLC12A7 ATP2B2 ATP2B4 | 1.30e-09 | 1249 | 158 | 32 | GO:0048878 |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | OR51A4 OR51A2 OR5B3 OR5T3 OR5B2 OR5D14 OR10J3 OR5AN1 OR5T2 OR5A1 OR8U3 OR11H12 ITPR3 OR1D2 OR52I2 OR5J2 TAS2R14 OR10J4 OR11H2 CFAP69 OR4C5 | 1.33e-09 | 547 | 158 | 21 | GO:0007606 |
| GeneOntologyBiologicalProcess | intracellular monoatomic cation homeostasis | CACNA1C GPR89B CACNA1F CACNA1S SPNS1 TRPC7 ATP13A1 SLC24A3 GRIK2 MCOLN1 SLC9C2 RYR2 ITPR3 EFHC1 HPS1 SCN7A SLC9A7 GPR89A CCR1 ATP12A ATP2B2 ATP2B4 | 1.71e-09 | 611 | 158 | 22 | GO:0030003 |
| GeneOntologyBiologicalProcess | intracellular monoatomic ion homeostasis | CACNA1C GPR89B CACNA1F CACNA1S SPNS1 TRPC7 ATP13A1 SLC24A3 GRIK2 MCOLN1 SLC9C2 RYR2 ITPR3 EFHC1 HPS1 SCN7A SLC9A7 GPR89A CCR1 ATP12A ATP2B2 ATP2B4 | 2.37e-09 | 622 | 158 | 22 | GO:0006873 |
| GeneOntologyBiologicalProcess | sensory perception of smell | OR51A4 OR51A2 OR5B3 OR5T3 OR5B2 OR5D14 OR10J3 OR5AN1 OR5T2 OR5A1 OR8U3 OR11H12 OR1D2 OR52I2 OR5J2 OR10J4 OR11H2 CFAP69 OR4C5 | 3.13e-09 | 465 | 158 | 19 | GO:0007608 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR51A4 OR51A2 OR5B3 OR5T3 OR5B2 OR5D14 OR10J3 OR5AN1 OR5T2 OR5A1 OR8U3 OR11H12 RYR2 OR1D2 OR52I2 OR5J2 TAS2R14 OR10J4 OR11H2 OR4C5 | 3.75e-09 | 524 | 158 | 20 | GO:0009593 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | OR51A4 OR51A2 OR5B3 OR5T3 OR5B2 OR5D14 OR10J3 OR5AN1 OR5T2 OR5A1 OR8U3 OR11H12 OR1D2 OR52I2 OR5J2 OR10J4 OR11H2 OR4C5 | 6.19e-09 | 432 | 158 | 18 | GO:0050911 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR51A4 OR51A2 OR5B3 OR5T3 OR5B2 OR5D14 OR10J3 OR5AN1 OR5T2 OR5A1 OR8U3 OR11H12 OR1D2 OR52I2 OR5J2 TAS2R14 OR10J4 OR11H2 OR4C5 | 6.22e-09 | 485 | 158 | 19 | GO:0050907 |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 9.38e-09 | 36 | 158 | 7 | GO:0086010 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 2.23e-08 | 87 | 158 | 9 | GO:0086001 | |
| GeneOntologyBiologicalProcess | potassium ion transmembrane transport | SLC12A6 CACNA1D SLC24A3 GRIK1 MCOLN1 SLC9C2 LRRC52 KCNQ5 KCNK10 KCNK2 SLC9A7 ATP12A SLC12A7 | 2.89e-08 | 232 | 158 | 13 | GO:0071805 |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | 4.01e-08 | 93 | 158 | 9 | GO:0086003 | |
| GeneOntologyBiologicalProcess | potassium ion transport | SLC12A6 CACNA1D SLC24A3 GRIK1 MCOLN1 SLC9C2 LRRC52 KCNQ5 KCNK10 KCNK2 SLC9A7 ATP12A SLC12A7 | 1.85e-07 | 272 | 158 | 13 | GO:0006813 |
| GeneOntologyBiologicalProcess | inorganic ion homeostasis | SLC12A6 CACNA1C CACNA1F CACNA1S TRPC7 ATP13A1 SLC24A3 GRIK2 MCOLN1 RYR2 ITPR3 EFHC1 HPS1 SCN7A CCR1 ATP12A SLC12A7 ATP2B2 ATP2B4 | 3.11e-07 | 622 | 158 | 19 | GO:0098771 |
| GeneOntologyBiologicalProcess | heart contraction | CACNA1C CACNA1D SCN11A CHRM2 RYR2 SCN1A GJD3 SCN2A SCN3A SCN7A SCN8A ATP2B2 ATP2B4 | 5.24e-07 | 298 | 158 | 13 | GO:0060047 |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 5.93e-07 | 127 | 158 | 9 | GO:0070252 | |
| GeneOntologyBiologicalProcess | intracellular calcium ion homeostasis | CACNA1C CACNA1F CACNA1S TRPC7 ATP13A1 SLC24A3 GRIK2 MCOLN1 RYR2 ITPR3 EFHC1 CCR1 ATP2B2 ATP2B4 | 7.26e-07 | 359 | 158 | 14 | GO:0006874 |
| GeneOntologyBiologicalProcess | heart process | CACNA1C CACNA1D SCN11A CHRM2 RYR2 SCN1A GJD3 SCN2A SCN3A SCN7A SCN8A ATP2B2 ATP2B4 | 7.89e-07 | 309 | 158 | 13 | GO:0003015 |
| GeneOntologyBiologicalProcess | calcium-mediated signaling | CACNA1C CACNA1D GRIK1 MCOLN1 RYR2 TPCN1 ITPR3 FCGR3A CCR1 CCR3 CCR6 ATP2B4 | 1.03e-06 | 266 | 158 | 12 | GO:0019722 |
| GeneOntologyBiologicalProcess | calcium ion import across plasma membrane | 1.73e-06 | 48 | 158 | 6 | GO:0098703 | |
| GeneOntologyBiologicalProcess | calcium ion import into cytosol | 1.73e-06 | 48 | 158 | 6 | GO:1902656 | |
| GeneOntologyBiologicalProcess | calcium ion homeostasis | CACNA1C CACNA1F CACNA1S TRPC7 ATP13A1 SLC24A3 GRIK2 MCOLN1 RYR2 ITPR3 EFHC1 CCR1 ATP2B2 ATP2B4 | 1.87e-06 | 389 | 158 | 14 | GO:0055074 |
| GeneOntologyBiologicalProcess | calcium ion transport | CACNA1C CACNA1D CACNA1F CACNA1S SCN11A TRPC7 SLC24A3 MCOLN1 RYR2 TPCN1 ITPR3 CCR1 TRPV3 SARAF ATP2B2 ATP2B4 | 1.96e-06 | 509 | 158 | 16 | GO:0006816 |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | CACNA1C CACNA1D CACNA1F CACNA1S SCN11A TRPC7 SLC24A3 MCOLN1 RYR2 TPCN1 ITPR3 TRPV3 ATP2B2 ATP2B4 | 2.05e-06 | 392 | 158 | 14 | GO:0070588 |
| GeneOntologyBiologicalProcess | import into cell | SLC12A6 CACNA1C CACNA1D CACNA1F CACNA1S SLC9C2 AP3M1 SLC1A4 SLC5A1 TPCN1 SLC5A3 SLC6A2 ACSL1 FCGR3A FCGR3B SLC22A4 SLC9A7 C3 TRPV3 LRRC8B ATP12A SLC12A7 LMBRD1 ATP2B4 | 2.28e-06 | 1074 | 158 | 24 | GO:0098657 |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | SLC12A6 CACNA1C ERBB4 HTR3A RASGRF1 RTN4 GRIK1 GRIK2 CHRM2 SLC1A4 ITPR3 SLC6A2 CYFIP1 NISCH ANAPC2 VPS13A KCNK2 SORCS3 HTR3B SLC12A7 ATP2B2 GABBR1 | 2.59e-06 | 931 | 158 | 22 | GO:0098916 |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | SLC12A6 CACNA1C ERBB4 HTR3A RASGRF1 RTN4 GRIK1 GRIK2 CHRM2 SLC1A4 ITPR3 SLC6A2 CYFIP1 NISCH ANAPC2 VPS13A KCNK2 SORCS3 HTR3B SLC12A7 ATP2B2 GABBR1 | 2.59e-06 | 931 | 158 | 22 | GO:0007268 |
| GeneOntologyBiologicalProcess | actin filament-based movement | 2.81e-06 | 153 | 158 | 9 | GO:0030048 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | SLC12A6 CACNA1C ERBB4 HTR3A RASGRF1 RTN4 GRIK1 GRIK2 CHRM2 SLC1A4 ITPR3 SLC6A2 CYFIP1 NISCH ANAPC2 VPS13A KCNK2 SORCS3 HTR3B SLC12A7 ATP2B2 GABBR1 | 2.97e-06 | 939 | 158 | 22 | GO:0099537 |
| GeneOntologyBiologicalProcess | action potential | CACNA1C CACNA1D SCN11A GRIK2 RYR2 SCN1A SCN2A SCN3A SCN7A SCN8A | 3.53e-06 | 201 | 158 | 10 | GO:0001508 |
| GeneOntologyBiologicalProcess | circulatory system process | CACNA1C CACNA1D SCN11A SLC24A3 CHRM2 SLC1A4 RYR2 SLC5A1 SLC5A3 CORO2B SCN1A NISCH GJD3 SCN2A SCN3A SCN7A SCN8A ATP2B2 ATP2B4 | 3.56e-06 | 733 | 158 | 19 | GO:0003013 |
| GeneOntologyBiologicalProcess | membrane depolarization | 4.29e-06 | 121 | 158 | 8 | GO:0051899 | |
| GeneOntologyBiologicalProcess | myo-inositol transport | 4.36e-06 | 5 | 158 | 3 | GO:0015798 | |
| GeneOntologyBiologicalProcess | synaptic signaling | SLC12A6 CACNA1C ERBB4 HTR3A RASGRF1 RTN4 GRIK1 GRIK2 CHRM2 SLC1A4 ITPR3 SLC6A2 CYFIP1 NISCH ANAPC2 VPS13A KCNK2 SORCS3 HTR3B SLC12A7 ATP2B2 GABBR1 | 5.51e-06 | 976 | 158 | 22 | GO:0099536 |
| GeneOntologyBiologicalProcess | cardiac muscle contraction | 5.76e-06 | 167 | 158 | 9 | GO:0060048 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | CACNA1C CACNA1D SCN11A HTR3A GRIK1 GRIK2 RYR2 SCN1A SCN2A SCN3A SCN7A SCN8A KCNK10 KCNK2 HTR3B GABBR1 | 6.47e-06 | 559 | 158 | 16 | GO:0042391 |
| GeneOntologyBiologicalProcess | striated muscle contraction | CACNA1C CACNA1D CACNA1S SCN11A RYR2 SCN1A SCN2A SCN3A SCN7A SCN8A | 6.96e-06 | 217 | 158 | 10 | GO:0006941 |
| GeneOntologyBiologicalProcess | neuronal action potential | 8.70e-06 | 63 | 158 | 6 | GO:0019228 | |
| GeneOntologyBiologicalProcess | monoatomic anion transport | SLC12A6 GPR89B MCOLN1 SLC1A4 SLC5A1 GPR89A LRRC8B SLC5A8 SLC12A7 | 1.21e-05 | 183 | 158 | 9 | GO:0006820 |
| GeneOntologyBiologicalProcess | organic cation transport | 1.63e-05 | 145 | 158 | 8 | GO:0015695 | |
| GeneOntologyBiologicalProcess | amino acid transport | SLC38A9 GRIK1 SLC7A7 SLC1A4 SLC6A2 SLC22A4 LRRC8B SLC38A11 GABBR1 | 2.00e-05 | 195 | 158 | 9 | GO:0006865 |
| GeneOntologyBiologicalProcess | organic hydroxy compound transport | RTN4 SLC5A1 SLC5A3 SLC5A11 SLC6A2 ABCG1 SLC10A5 NISCH ABCD3 SLC5A8 SLC51A GABBR1 | 2.12e-05 | 358 | 158 | 12 | GO:0015850 |
| GeneOntologyBiologicalProcess | monoatomic anion transmembrane transport | 2.40e-05 | 153 | 158 | 8 | GO:0098656 | |
| GeneOntologyBiologicalProcess | carboxylic acid transmembrane transport | 3.78e-05 | 163 | 158 | 8 | GO:1905039 | |
| GeneOntologyBiologicalProcess | amino acid transmembrane transport | 3.91e-05 | 120 | 158 | 7 | GO:0003333 | |
| GeneOntologyBiologicalProcess | organic anion transport | SLC38A9 SLC35B3 GRIK1 SLC7A7 SLC1A4 ACSL1 SLC10A5 ABCD3 LRRC8B SLC38A11 SLC5A8 SLC51A SLC33A1 GABBR1 | 4.40e-05 | 515 | 158 | 14 | GO:0015711 |
| GeneOntologyBiologicalProcess | organic acid transmembrane transport | 4.49e-05 | 167 | 158 | 8 | GO:1903825 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane import into cytosol | CACNA1C CACNA1D CACNA1F CACNA1S MCOLN1 RYR2 ITPR3 TRPV3 ATP2B4 | 4.63e-05 | 217 | 158 | 9 | GO:0097553 |
| GeneOntologyBiologicalProcess | perforin production | 5.83e-05 | 2 | 158 | 2 | GO:0035944 | |
| GeneOntologyBiologicalProcess | fucose transmembrane transport | 5.83e-05 | 2 | 158 | 2 | GO:0015756 | |
| GeneOntologyBiologicalProcess | pentose transmembrane transport | 5.83e-05 | 2 | 158 | 2 | GO:0015750 | |
| GeneOntologyBiologicalProcess | muscle contraction | CACNA1C CACNA1D CACNA1S SCN11A CHRM2 RYR2 SCN1A SCN2A SCN3A SCN7A SCN8A ATP2B4 | 6.21e-05 | 400 | 158 | 12 | GO:0006936 |
| GeneOntologyBiologicalProcess | regulation of cardiac conduction | 6.78e-05 | 29 | 158 | 4 | GO:1903779 | |
| GeneOntologyBiologicalProcess | carboxylic acid transport | SLC38A9 GRIK1 SLC7A7 SLC1A4 ACSL1 SLC10A5 ABCD3 LRRC8B SLC38A11 SLC5A8 SLC51A GABBR1 | 7.85e-05 | 410 | 158 | 12 | GO:0046942 |
| GeneOntologyBiologicalProcess | organic acid transport | SLC38A9 GRIK1 SLC7A7 SLC1A4 ACSL1 SLC10A5 ABCD3 LRRC8B SLC38A11 SLC5A8 SLC51A GABBR1 | 8.22e-05 | 412 | 158 | 12 | GO:0015849 |
| GeneOntologyBiologicalProcess | carbohydrate derivative transport | 9.65e-05 | 96 | 158 | 6 | GO:1901264 | |
| GeneOntologyBiologicalProcess | regulation of presynaptic membrane potential | 1.01e-04 | 32 | 158 | 4 | GO:0099505 | |
| GeneOntologyBiologicalProcess | calcium ion import | 1.08e-04 | 98 | 158 | 6 | GO:0070509 | |
| GeneOntologyBiologicalProcess | cardiac conduction | 1.21e-04 | 100 | 158 | 6 | GO:0061337 | |
| GeneOntologyBiologicalProcess | blood circulation | CACNA1C CACNA1D SCN11A CHRM2 RYR2 CORO2B SCN1A NISCH GJD3 SCN2A SCN3A SCN7A SCN8A ATP2B2 ATP2B4 | 1.42e-04 | 648 | 158 | 15 | GO:0008015 |
| GeneOntologyBiologicalProcess | behavior | CACNA1C SCN11A RASGRF1 GRIK1 GRIK2 ITPR3 GPR83 SCN1A SCN2A SCN3A SCN8A VPS13A KCNK10 KCNK2 SORCS3 CYP7B1 CFAP69 ATP2B2 | 1.68e-04 | 891 | 158 | 18 | GO:0007610 |
| GeneOntologyBiologicalProcess | type IIa hypersensitivity | 1.88e-04 | 15 | 158 | 3 | GO:0001794 | |
| GeneOntologyBiologicalProcess | AV node cell to bundle of His cell communication | 1.88e-04 | 15 | 158 | 3 | GO:0086067 | |
| GeneOntologyBiologicalProcess | type II hypersensitivity | 1.88e-04 | 15 | 158 | 3 | GO:0002445 | |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | 2.25e-04 | 112 | 158 | 6 | GO:0019226 | |
| GeneOntologyBiologicalProcess | cellular response to osmotic stress | 2.29e-04 | 72 | 158 | 5 | GO:0071470 | |
| GeneOntologyBiologicalProcess | organophosphate ester transport | 2.56e-04 | 162 | 158 | 7 | GO:0015748 | |
| GeneOntologyBiologicalProcess | regulation of pH | 3.27e-04 | 120 | 158 | 6 | GO:0006885 | |
| GeneOntologyBiologicalProcess | calcium ion export | 3.46e-04 | 4 | 158 | 2 | GO:1901660 | |
| GeneOntologyBiologicalProcess | ammonium import across plasma membrane | 3.46e-04 | 4 | 158 | 2 | GO:0140157 | |
| GeneOntologyBiologicalProcess | negative regulation of synaptic transmission | 3.75e-04 | 80 | 158 | 5 | GO:0050805 | |
| GeneOntologyBiologicalProcess | cognition | CACNA1C RASGRF1 SLC1A4 ITPR3 CYFIP1 SCN2A KCNK10 KCNK2 SORCS3 CYP7B1 DOP1B | 4.30e-04 | 423 | 158 | 11 | GO:0050890 |
| GeneOntologyBiologicalProcess | memory | 5.34e-04 | 183 | 158 | 7 | GO:0007613 | |
| GeneOntologyBiologicalProcess | transport across blood-brain barrier | 5.52e-04 | 87 | 158 | 5 | GO:0150104 | |
| GeneOntologyBiologicalProcess | central nervous system vasculogenesis | 5.74e-04 | 5 | 158 | 2 | GO:0022009 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel | 5.74e-04 | 5 | 158 | 2 | GO:1904879 | |
| GeneOntologyBiologicalProcess | regulation of arginine metabolic process | 5.74e-04 | 5 | 158 | 2 | GO:0000821 | |
| GeneOntologyBiologicalProcess | nucleotide transport | 5.80e-04 | 50 | 158 | 4 | GO:0006862 | |
| GeneOntologyBiologicalProcess | vascular transport | 5.81e-04 | 88 | 158 | 5 | GO:0010232 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | CACNA1C GPR89B CACNA1D CACNA1F CACNA1S SCN11A TRPC7 HTR3A GRIK1 GRIK2 RYR2 LRRC52 TPCN1 SLC5A3 KCNQ5 SCN1A SCN2A SCN3A SCN7A SCN8A KCNK10 KCNK2 GPR89A LRRC8B HTR3B | 1.29e-16 | 378 | 159 | 25 | GO:0034702 |
| GeneOntologyCellularComponent | cation channel complex | CACNA1C CACNA1D CACNA1F CACNA1S SCN11A TRPC7 HTR3A GRIK1 GRIK2 RYR2 LRRC52 SLC5A3 KCNQ5 SCN1A SCN2A SCN3A SCN7A SCN8A KCNK2 HTR3B | 1.46e-15 | 235 | 159 | 20 | GO:0034703 |
| GeneOntologyCellularComponent | transmembrane transporter complex | CACNA1C GPR89B CACNA1D CACNA1F CACNA1S SCN11A TRPC7 HTR3A GRIK1 GRIK2 RYR2 LRRC52 TPCN1 SLC5A3 KCNQ5 SCN1A SCN2A SCN3A SCN7A SCN8A KCNK10 KCNK2 GPR89A LRRC8B HTR3B ATP12A | 2.74e-14 | 523 | 159 | 26 | GO:1902495 |
| GeneOntologyCellularComponent | transporter complex | CACNA1C GPR89B CACNA1D CACNA1F CACNA1S SCN11A TRPC7 HTR3A GRIK1 GRIK2 RYR2 LRRC52 TPCN1 SLC5A3 KCNQ5 SCN1A SCN2A SCN3A SCN7A SCN8A KCNK10 KCNK2 GPR89A LRRC8B HTR3B ATP12A | 8.85e-14 | 550 | 159 | 26 | GO:1990351 |
| GeneOntologyCellularComponent | sodium channel complex | 3.52e-11 | 29 | 159 | 8 | GO:0034706 | |
| GeneOntologyCellularComponent | membrane protein complex | CACNA1C GPR89B CACNA1D CACNA1F CACNA1S SCN11A TRPC7 HTR3A RPN1 SLC38A9 SRPRA GRIK1 GRIK2 AP3M1 RYR2 LRRC52 TPCN1 SLC5A3 CD247 KCNQ5 TIMM21 FCGR3A FCGR3B SCN1A GJD3 SCN2A SCN3A SCN7A SCN8A KCNK10 KCNK2 GPR89A LRRC8B HTR3B SYVN1 ATP12A GABBR1 | 1.16e-10 | 1498 | 159 | 37 | GO:0098796 |
| GeneOntologyCellularComponent | presynaptic membrane | CACNA1C CACNA1D SCN11A ERBB4 HTR3A GRIK1 GRIK2 CHRM2 SLC6A2 KCNQ5 SCN1A SCN2A SCN8A ATP2B2 ATP2B4 GABBR1 | 3.93e-10 | 277 | 159 | 16 | GO:0042734 |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 2.03e-09 | 17 | 159 | 6 | GO:0001518 | |
| GeneOntologyCellularComponent | neuronal cell body | CACNA1C CACNA1D CACNA1F SCN11A ERBB4 HTR3A RASGRF1 RTN4 GRIK1 GRIK2 CHRM2 SLC1A4 ITPR3 SLC6A2 EFHC1 CYFIP1 SCN1A SCN3A SCN8A VPS13A KCNK2 CCR1 HTR3B ATP2B2 GABBR1 | 4.52e-09 | 835 | 159 | 25 | GO:0043025 |
| GeneOntologyCellularComponent | plasma membrane protein complex | CACNA1C CACNA1D CACNA1F CACNA1S SCN11A HTR3A GRIK1 GRIK2 LRRC52 SLC5A3 CD247 KCNQ5 FCGR3A FCGR3B SCN1A GJD3 SCN2A SCN3A SCN7A SCN8A KCNK2 HTR3B ATP12A GABBR1 | 6.37e-09 | 785 | 159 | 24 | GO:0098797 |
| GeneOntologyCellularComponent | cell body | PITPNM2 CACNA1C CACNA1D CACNA1F SCN11A ERBB4 HTR3A RASGRF1 RTN4 GRIK1 GRIK2 CHRM2 SLC1A4 ITPR3 SLC6A2 EFHC1 CYFIP1 SCN1A SCN3A SCN8A VPS13A KCNK2 CCR1 HTR3B ATP2B2 GABBR1 | 8.58e-09 | 929 | 159 | 26 | GO:0044297 |
| GeneOntologyCellularComponent | synaptic membrane | CACNA1C CACNA1D SCN11A ERBB4 HTR3A RTN4 GRIK1 GRIK2 CHRM2 SLC6A2 KCNQ5 SCN1A SCN2A SCN8A SORCS3 HTR3B ATP2B2 ATP2B4 GABBR1 | 1.04e-07 | 583 | 159 | 19 | GO:0097060 |
| GeneOntologyCellularComponent | Fc-gamma receptor III complex | 1.72e-06 | 4 | 159 | 3 | GO:0033001 | |
| GeneOntologyCellularComponent | somatodendritic compartment | CACNA1C CACNA1D CACNA1F CACNA1S SCN11A ERBB4 HTR3A RASGRF1 RTN4 GRIK1 GRIK2 CHRM2 SLC1A4 ITPR3 SLC6A2 EFHC1 CYFIP1 SCN1A SCN3A SCN8A VPS13A KCNK2 CCR1 HTR3B ATP2B2 GABBR1 | 1.96e-06 | 1228 | 159 | 26 | GO:0036477 |
| GeneOntologyCellularComponent | postsynaptic density membrane | 2.75e-05 | 157 | 159 | 8 | GO:0098839 | |
| GeneOntologyCellularComponent | T-tubule | 3.10e-05 | 79 | 159 | 6 | GO:0030315 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | OR5T3 RPN1 ATP13A1 DNAJC16 RTN4 SLC35B3 SRPRA PIGG RYR2 ITPR3 ACSL1 ABCG1 MBTPS2 VPS13A KCNK2 CYP7B1 LRRC8B SARAF HAS2 SYVN1 SLC51A LMBRD1 SLC33A1 GABBR1 | 4.43e-05 | 1293 | 159 | 24 | GO:0005789 |
| GeneOntologyCellularComponent | presynapse | CACNA1C CACNA1D SCN11A ERBB4 HTR3A GRIK1 GRIK2 CHRM2 ITPR3 SLC6A2 CYFIP1 KCNQ5 SCN1A SCN2A SCN8A KCNK2 ATP2B2 ATP2B4 GABBR1 | 4.55e-05 | 886 | 159 | 19 | GO:0098793 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | OR5T3 RPN1 ATP13A1 DNAJC16 RTN4 SLC35B3 SRPRA PIGG RYR2 ITPR3 ACSL1 ABCG1 MBTPS2 VPS13A KCNK2 CYP7B1 LRRC8B SARAF HAS2 SYVN1 SLC51A LMBRD1 SLC33A1 GABBR1 | 4.77e-05 | 1299 | 159 | 24 | GO:0098827 |
| GeneOntologyCellularComponent | axon | SLC12A6 CACNA1C SCN11A HTR3A RASGRF1 GRIK1 GRIK2 CHRM2 AP3M1 SLC6A2 CYFIP1 KCNQ5 SCN1A SCN2A SCN3A SCN8A KCNK2 HTR3B GABBR1 | 4.91e-05 | 891 | 159 | 19 | GO:0030424 |
| GeneOntologyCellularComponent | postsynaptic membrane | CACNA1C ERBB4 HTR3A RTN4 GRIK1 GRIK2 CHRM2 SCN8A SORCS3 HTR3B ATP2B2 GABBR1 | 6.55e-05 | 405 | 159 | 12 | GO:0045211 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | OR5T3 RPN1 ATP13A1 DNAJC16 RTN4 SLC35B3 SRPRA PIGG RYR2 ITPR3 ACSL1 ABCG1 MBTPS2 VPS13A KCNK2 CYP7B1 LRRC8B SARAF HAS2 SYVN1 SLC51A LMBRD1 SLC33A1 GABBR1 | 6.67e-05 | 1327 | 159 | 24 | GO:0042175 |
| GeneOntologyCellularComponent | L-type voltage-gated calcium channel complex | 9.03e-05 | 12 | 159 | 3 | GO:1990454 | |
| GeneOntologyCellularComponent | Fc receptor complex | 9.03e-05 | 12 | 159 | 3 | GO:0032997 | |
| GeneOntologyCellularComponent | apical plasma membrane | SLC12A6 CACNA1D SLC5A10 SLC5A1 SLC5A3 ITPR3 SLC5A11 ADGRG2 SLC22A4 KCNK2 SLC5A8 ATP12A ATP2B2 | 9.32e-05 | 487 | 159 | 13 | GO:0016324 |
| GeneOntologyCellularComponent | potassium channel complex | 1.45e-04 | 104 | 159 | 6 | GO:0034705 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 1.56e-04 | 201 | 159 | 8 | GO:0099634 | |
| GeneOntologyCellularComponent | calcium channel complex | 2.37e-04 | 73 | 159 | 5 | GO:0034704 | |
| GeneOntologyCellularComponent | I band | 2.85e-04 | 166 | 159 | 7 | GO:0031674 | |
| GeneOntologyCellularComponent | basal plasma membrane | SLC12A6 ERBB4 RASGRF1 SLC7A7 SLC5A3 SLC22A4 ATP12A SLC51A ATP2B2 ATP2B4 | 3.92e-04 | 354 | 159 | 10 | GO:0009925 |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 4.10e-04 | 46 | 159 | 4 | GO:0005891 | |
| GeneOntologyCellularComponent | node of Ranvier | 4.48e-04 | 20 | 159 | 3 | GO:0033268 | |
| GeneOntologyCellularComponent | lysosome | SPNS1 SLC38A9 LAPTM4B CD164 DTX3L MCOLN1 AP3M1 PGAP6 EPG5 TPCN1 HPS1 VPS13A C3 TRPV3 HAS2 LMBRD1 | 4.72e-04 | 811 | 159 | 16 | GO:0005764 |
| GeneOntologyCellularComponent | lytic vacuole | SPNS1 SLC38A9 LAPTM4B CD164 DTX3L MCOLN1 AP3M1 PGAP6 EPG5 TPCN1 HPS1 VPS13A C3 TRPV3 HAS2 LMBRD1 | 4.72e-04 | 811 | 159 | 16 | GO:0000323 |
| GeneOntologyCellularComponent | neurotransmitter receptor complex | 5.65e-04 | 50 | 159 | 4 | GO:0098878 | |
| GeneOntologyCellularComponent | serotonin-activated cation-selective channel complex | 5.66e-04 | 5 | 159 | 2 | GO:1904602 | |
| GeneOntologyCellularComponent | serotonin receptor complex | 5.66e-04 | 5 | 159 | 2 | GO:0098665 | |
| GeneOntologyCellularComponent | apical part of cell | SLC12A6 CACNA1D SLC5A10 SLC5A1 SLC5A3 ITPR3 SLC5A11 ADGRG2 SLC22A4 KCNK2 SLC5A8 ATP12A ATP2B2 | 6.12e-04 | 592 | 159 | 13 | GO:0045177 |
| GeneOntologyCellularComponent | sarcolemma | 6.40e-04 | 190 | 159 | 7 | GO:0042383 | |
| GeneOntologyCellularComponent | basal part of cell | SLC12A6 ERBB4 RASGRF1 SLC7A7 SLC5A3 SLC22A4 ATP12A SLC51A ATP2B2 ATP2B4 | 6.52e-04 | 378 | 159 | 10 | GO:0045178 |
| GeneOntologyCellularComponent | basolateral plasma membrane | SLC12A6 ERBB4 RASGRF1 SLC7A7 SLC5A3 ATP12A SLC51A ATP2B2 ATP2B4 | 7.89e-04 | 320 | 159 | 9 | GO:0016323 |
| GeneOntologyCellularComponent | lysosomal membrane | SPNS1 SLC38A9 LAPTM4B CD164 DTX3L MCOLN1 AP3M1 PGAP6 TPCN1 VPS13A LMBRD1 | 8.41e-04 | 462 | 159 | 11 | GO:0005765 |
| GeneOntologyCellularComponent | lytic vacuole membrane | SPNS1 SLC38A9 LAPTM4B CD164 DTX3L MCOLN1 AP3M1 PGAP6 TPCN1 VPS13A LMBRD1 | 8.41e-04 | 462 | 159 | 11 | GO:0098852 |
| GeneOntologyCellularComponent | kainate selective glutamate receptor complex | 8.45e-04 | 6 | 159 | 2 | GO:0032983 | |
| GeneOntologyCellularComponent | Z disc | 1.06e-03 | 151 | 159 | 6 | GO:0030018 | |
| GeneOntologyCellularComponent | axon initial segment | 1.36e-03 | 29 | 159 | 3 | GO:0043194 | |
| GeneOntologyCellularComponent | vacuole | SPNS1 SLC38A9 LAPTM4B CD164 DTX3L MCOLN1 AP3M1 PGAP6 EPG5 TPCN1 HPS1 VPS13A C3 TRPV3 HAS2 LMBRD1 | 1.64e-03 | 913 | 159 | 16 | GO:0005773 |
| GeneOntologyCellularComponent | vacuolar membrane | SPNS1 SLC38A9 LAPTM4B CD164 DTX3L MCOLN1 AP3M1 PGAP6 TPCN1 VPS13A LMBRD1 | 1.77e-03 | 507 | 159 | 11 | GO:0005774 |
| GeneOntologyCellularComponent | presynaptic active zone membrane | 2.97e-03 | 78 | 159 | 4 | GO:0048787 | |
| GeneOntologyCellularComponent | sarcomere | 3.01e-03 | 249 | 159 | 7 | GO:0030017 | |
| GeneOntologyCellularComponent | SCAR complex | 3.61e-03 | 12 | 159 | 2 | GO:0031209 | |
| GeneOntologyCellularComponent | glutamatergic synapse | CACNA1C SCN11A ERBB4 HTR3A RTN4 GRIK1 GRIK2 CHRM2 SCN2A SCN8A SORCS3 ATP2B2 ATP2B4 GABBR1 | 3.90e-03 | 817 | 159 | 14 | GO:0098978 |
| GeneOntologyCellularComponent | main axon | 4.77e-03 | 89 | 159 | 4 | GO:0044304 | |
| GeneOntologyCellularComponent | myofibril | 4.98e-03 | 273 | 159 | 7 | GO:0030016 | |
| GeneOntologyCellularComponent | voltage-gated potassium channel complex | 5.16e-03 | 91 | 159 | 4 | GO:0008076 | |
| GeneOntologyCellularComponent | axon terminus | 5.48e-03 | 210 | 159 | 6 | GO:0043679 | |
| GeneOntologyCellularComponent | dendrite | CACNA1C CACNA1D CACNA1S ERBB4 RASGRF1 GRIK1 GRIK2 CHRM2 SLC1A4 ITPR3 CYFIP1 SCN8A ATP2B2 GABBR1 | 5.96e-03 | 858 | 159 | 14 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | CACNA1C CACNA1D CACNA1S ERBB4 RASGRF1 GRIK1 GRIK2 CHRM2 SLC1A4 ITPR3 CYFIP1 SCN8A ATP2B2 GABBR1 | 6.08e-03 | 860 | 159 | 14 | GO:0097447 |
| GeneOntologyCellularComponent | contractile muscle fiber | 6.86e-03 | 290 | 159 | 7 | GO:0043292 | |
| MousePheno | abnormal synaptic transmission | SLC12A6 CACNA1C SPNS1 SCN11A ERBB4 TRIB2 RASGRF1 RTN4 LAPTM4B GRIK1 GRIK2 CHRM2 RYR2 CYFIP2 EPG5 SLC6A2 CD247 CYFIP1 SCN1A SCN2A SCN8A VPS13A SORCS3 C3 GABBR1 | 6.22e-07 | 1070 | 110 | 25 | MP:0003635 |
| MousePheno | abnormal synaptic physiology | SLC12A6 CACNA1C SPNS1 SCN11A ERBB4 TRIB2 RASGRF1 RTN4 LAPTM4B GRIK1 GRIK2 CHRM2 RYR2 CYFIP2 EPG5 SLC6A2 CD247 CYFIP1 SCN1A SCN2A SCN8A VPS13A SORCS3 C3 GABBR1 | 6.91e-07 | 1076 | 110 | 25 | MP:0021009 |
| MousePheno | abnormal sensory capabilities/reflexes/nociception | DOCK3 SLC12A6 CACNA1C CACNA1D CACNA1S SCN11A TRIB2 HTR3A RTN4 LAPTM4B GRIK1 SERINC2 SLC7A7 MCOLN1 CHRM2 RYR2 CYFIP2 EPG5 SLC6A2 SCN1A SCN8A ABCD3 TRPV3 SLC12A7 ATP2B2 SLC33A1 TRIB1 GABBR1 XPOT ANKS1A | 8.24e-07 | 1486 | 110 | 30 | MP:0002067 |
| MousePheno | abnormal touch/ nociception | SLC12A6 CACNA1C CACNA1S SCN11A HTR3A GRIK1 SLC7A7 CHRM2 SLC6A2 TRPV3 SLC33A1 TRIB1 GABBR1 XPOT | 1.44e-06 | 376 | 110 | 14 | MP:0001968 |
| MousePheno | abnormal nervous system electrophysiology | SLC12A6 CACNA1D SCN11A GRIK1 GRIK2 RYR2 SLC5A3 KCNQ5 SCN1A SCN2A SCN8A ATP2B2 GABBR1 | 1.83e-06 | 329 | 110 | 13 | MP:0002272 |
| MousePheno | abnormal CNS synaptic transmission | SLC12A6 CACNA1C SPNS1 SCN11A ERBB4 TRIB2 RASGRF1 RTN4 LAPTM4B GRIK1 GRIK2 CHRM2 RYR2 CYFIP2 EPG5 SLC6A2 CD247 CYFIP1 SCN1A SCN2A SORCS3 C3 GABBR1 | 1.95e-06 | 985 | 110 | 23 | MP:0002206 |
| MousePheno | limb grasping | DOCK3 SLC12A6 CACNA1S TRIB2 SERINC2 MCOLN1 EPG5 SCN8A ABCD3 ATP2B2 SLC33A1 ANKS1A | 9.32e-06 | 325 | 110 | 12 | MP:0001513 |
| MousePheno | abnormal action potential | 9.87e-06 | 133 | 110 | 8 | MP:0005402 | |
| MousePheno | abnormal behavioral response to xenobiotic | SLC12A6 GRIK2 CHRM2 RYR2 CYFIP2 SLC6A2 EFHC1 SCN1A SCN8A KCNK2 GABBR1 | 3.14e-05 | 309 | 110 | 11 | MP:0009745 |
| MousePheno | abnormal pain threshold | SLC12A6 CACNA1C SCN11A HTR3A GRIK1 CHRM2 SLC6A2 TRPV3 SLC33A1 GABBR1 | 4.78e-05 | 267 | 110 | 10 | MP:0001970 |
| MousePheno | spinal cord degeneration | 6.14e-05 | 2 | 110 | 2 | MP:0012712 | |
| MousePheno | abnormal reflex | DOCK3 SLC12A6 CACNA1D CACNA1S TRIB2 RTN4 LAPTM4B SERINC2 SLC7A7 MCOLN1 RYR2 CYFIP2 EPG5 SCN1A SCN8A ABCD3 SLC12A7 ATP2B2 SLC33A1 TRIB1 GABBR1 XPOT ANKS1A | 1.54e-04 | 1294 | 110 | 23 | MP:0001961 |
| MousePheno | abnormal seizure response to pharmacological agent | 1.59e-04 | 147 | 110 | 7 | MP:0000950 | |
| MousePheno | fibrillation | 1.62e-04 | 14 | 110 | 3 | MP:0006109 | |
| MousePheno | abnormal seizure response to inducing agent | 1.86e-04 | 201 | 110 | 8 | MP:0009357 | |
| MousePheno | abnormal spinal nerve morphology | 1.96e-04 | 107 | 110 | 6 | MP:0001077 | |
| MousePheno | irregular heartbeat | 2.37e-04 | 71 | 110 | 5 | MP:0001636 | |
| MousePheno | abnormal afterhyperpolarization | 2.97e-04 | 17 | 110 | 3 | MP:0003412 | |
| MousePheno | abnormal urine homeostasis | SLC5A10 HTR3A SLC7A7 SLC5A1 TPCN1 CORO2B HPS1 CCR1 C3 SLC5A8 ATP12A SLC12A7 | 2.98e-04 | 466 | 110 | 12 | MP:0009643 |
| MousePheno | increased susceptibility to pharmacologically induced seizures | 3.19e-04 | 117 | 110 | 6 | MP:0002906 | |
| MousePheno | increased susceptibility to induction of seizure by inducing agent | 3.34e-04 | 118 | 110 | 6 | MP:0012349 | |
| MousePheno | abnormal long-term potentiation | 3.53e-04 | 221 | 110 | 8 | MP:0002207 | |
| MousePheno | abnormal sensory ganglion morphology | 3.53e-04 | 221 | 110 | 8 | MP:0000960 | |
| MousePheno | decreased paired-pulse ratio | 3.64e-04 | 4 | 110 | 2 | MP:0014253 | |
| MousePheno | abnormal chemical nociception | 3.87e-04 | 44 | 110 | 4 | MP:0002735 | |
| MousePheno | hypoalgesia | 3.87e-04 | 170 | 110 | 7 | MP:0003043 | |
| MousePheno | impaired behavioral response to xenobiotic | 4.91e-04 | 83 | 110 | 5 | MP:0009747 | |
| MousePheno | cochlear outer hair cell degeneration | 5.78e-04 | 86 | 110 | 5 | MP:0004404 | |
| MousePheno | enlarged thymus cortex | 6.04e-04 | 5 | 110 | 2 | MP:0013593 | |
| Domain | Ion_trans_dom | CACNA1C CACNA1D CACNA1F CACNA1S SCN11A TRPC7 MCOLN1 RYR2 TPCN1 ITPR3 KCNQ5 SCN1A SCN2A SCN3A SCN7A SCN8A TRPV3 | 6.41e-17 | 114 | 155 | 17 | IPR005821 |
| Domain | Ion_trans | CACNA1C CACNA1D CACNA1F CACNA1S SCN11A TRPC7 MCOLN1 RYR2 TPCN1 ITPR3 KCNQ5 SCN1A SCN2A SCN3A SCN7A SCN8A TRPV3 | 6.41e-17 | 114 | 155 | 17 | PF00520 |
| Domain | Channel_four-helix_dom | CACNA1C CACNA1D CACNA1F CACNA1S SCN11A SLC9C2 TPCN1 SCN1A SCN2A SCN3A SCN7A SCN8A | 3.56e-14 | 57 | 155 | 12 | IPR027359 |
| Domain | - | CACNA1C CACNA1D CACNA1F CACNA1S SCN11A SLC9C2 TPCN1 SCN1A SCN2A SCN3A SCN7A SCN8A | 3.56e-14 | 57 | 155 | 12 | 1.20.120.350 |
| Domain | Na_channel_asu | 6.06e-11 | 10 | 155 | 6 | IPR001696 | |
| Domain | Na_trans_assoc | 6.06e-11 | 10 | 155 | 6 | IPR010526 | |
| Domain | Na_trans_assoc | 6.06e-11 | 10 | 155 | 6 | PF06512 | |
| Domain | VDCC_L_a1su | 4.56e-09 | 4 | 155 | 4 | IPR005446 | |
| Domain | SSF | 2.79e-08 | 12 | 155 | 5 | PF00474 | |
| Domain | NA_SOLUT_SYMP_2 | 2.79e-08 | 12 | 155 | 5 | PS00457 | |
| Domain | Na/solute_symporter | 2.79e-08 | 12 | 155 | 5 | IPR001734 | |
| Domain | NA_SOLUT_SYMP_3 | 2.79e-08 | 12 | 155 | 5 | PS50283 | |
| Domain | Olfact_rcpt | OR51A4 OR51A2 OR5B3 OR5T3 OR5B2 OR5D14 OR10J3 OR5AN1 OR5T2 OR5A1 OR8U3 OR11H12 OR1D2 OR52I2 OR5J2 OR11H2 OR4C5 | 3.03e-08 | 393 | 155 | 17 | IPR000725 |
| Domain | G_PROTEIN_RECEP_F1_2 | OR51A4 OR51A2 OR5B3 OR5T3 OR5B2 OR5D14 OR10J3 OR5AN1 OR5T2 OR5A1 OR8U3 OR11H12 CHRM2 OR1D2 GPR83 OR52I2 OR5J2 CCR1 CCR3 CCR6 OR11H2 OR4C5 | 6.35e-08 | 691 | 155 | 22 | PS50262 |
| Domain | GPCR_Rhodpsn | OR51A4 OR51A2 OR5B3 OR5T3 OR5B2 OR5D14 OR10J3 OR5AN1 OR5T2 OR5A1 OR8U3 OR11H12 CHRM2 OR1D2 GPR83 OR52I2 OR5J2 CCR1 CCR3 CCR6 OR11H2 OR4C5 | 6.51e-08 | 692 | 155 | 22 | IPR000276 |
| Domain | Na_trans_cytopl | 6.76e-08 | 6 | 155 | 4 | PF11933 | |
| Domain | Na_trans_cytopl | 6.76e-08 | 6 | 155 | 4 | IPR024583 | |
| Domain | Ca_chan_IQ | 1.57e-07 | 7 | 155 | 4 | SM01062 | |
| Domain | Ca_chan_IQ | 1.57e-07 | 7 | 155 | 4 | PF08763 | |
| Domain | VDCC_a1su_IQ | 1.57e-07 | 7 | 155 | 4 | IPR014873 | |
| Domain | GPHH | 1.57e-07 | 7 | 155 | 4 | PF16905 | |
| Domain | GPHH_dom | 1.57e-07 | 7 | 155 | 4 | IPR031649 | |
| Domain | GPCR_Rhodpsn_7TM | OR51A4 OR51A2 OR5B3 OR5T3 OR5B2 OR5D14 OR10J3 OR5AN1 OR5T2 OR5A1 OR8U3 OR11H12 CHRM2 OR1D2 GPR83 OR52I2 OR5J2 CCR1 CCR3 CCR6 OR11H2 | 1.69e-07 | 670 | 155 | 21 | IPR017452 |
| Domain | 7tm_1 | OR51A4 OR51A2 OR5B3 OR5T3 OR5B2 OR5D14 OR10J3 OR5AN1 OR5T2 OR5A1 OR8U3 OR11H12 CHRM2 OR1D2 GPR83 OR52I2 OR5J2 CCR1 CCR3 CCR6 OR4C5 | 2.01e-07 | 677 | 155 | 21 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | OR51A4 OR51A2 OR5B3 OR5T3 OR5B2 OR5D14 OR10J3 OR5AN1 OR5T2 OR5A1 OR8U3 OR11H12 CHRM2 OR1D2 GPR83 OR52I2 OR5J2 CCR1 CCR3 CCR6 OR4C5 | 2.44e-07 | 685 | 155 | 21 | PS00237 |
| Domain | CAC1F_C | 5.61e-07 | 3 | 155 | 3 | IPR031688 | |
| Domain | CAC1F_C | 5.61e-07 | 3 | 155 | 3 | PF16885 | |
| Domain | VDCCAlpha1 | 9.22e-07 | 10 | 155 | 4 | IPR002077 | |
| Domain | NA_SOLUT_SYMP_1 | 1.44e-06 | 11 | 155 | 4 | PS00456 | |
| Domain | EF-hand-dom_pair | CACNA1C CACNA1F CACNA1S TBC1D8B RYR2 TPCN1 MINDY3 EFHC1 SCN1A SCN3A SCN7A SCN8A | 5.07e-06 | 287 | 155 | 12 | IPR011992 |
| Domain | Na/solute_symporter_CS | 3.05e-05 | 8 | 155 | 3 | IPR018212 | |
| Domain | IQ | 5.76e-05 | 81 | 155 | 6 | SM00015 | |
| Domain | Cytoplasmic_FMR1-int | 6.84e-05 | 2 | 155 | 2 | IPR008081 | |
| Domain | 2pore_dom_K_chnl_TREK | 6.84e-05 | 2 | 155 | 2 | IPR003976 | |
| Domain | 5HT3_rcpt | 6.84e-05 | 2 | 155 | 2 | IPR008132 | |
| Domain | FragX_IP | 6.84e-05 | 2 | 155 | 2 | PF05994 | |
| Domain | IQ_motif_EF-hand-BS | 1.04e-04 | 90 | 155 | 6 | IPR000048 | |
| Domain | ATPase_P-typ_cyto_domN | 1.96e-04 | 35 | 155 | 4 | IPR023299 | |
| Domain | ATPase_P-typ_P_site | 2.19e-04 | 36 | 155 | 4 | IPR018303 | |
| Domain | P_typ_ATPase | 2.19e-04 | 36 | 155 | 4 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 2.19e-04 | 36 | 155 | 4 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 2.43e-04 | 37 | 155 | 4 | IPR008250 | |
| Domain | E1-E2_ATPase | 2.43e-04 | 37 | 155 | 4 | PF00122 | |
| Domain | Chemokine_rcpt | 2.90e-04 | 16 | 155 | 3 | IPR000355 | |
| Domain | ATPase_P-typ_TM_dom | 2.90e-04 | 16 | 155 | 3 | IPR023298 | |
| Domain | - | 2.90e-04 | 16 | 155 | 3 | 1.20.1110.10 | |
| Domain | ATPase_P-typ_cation-transptr_C | 3.50e-04 | 17 | 155 | 3 | IPR006068 | |
| Domain | Cation_ATPase_C | 3.50e-04 | 17 | 155 | 3 | PF00689 | |
| Domain | ATP_Ca_trans_C | 4.06e-04 | 4 | 155 | 2 | IPR022141 | |
| Domain | Pecanex_C | 4.06e-04 | 4 | 155 | 2 | PF05041 | |
| Domain | ATP_Ca_trans_C | 4.06e-04 | 4 | 155 | 2 | PF12424 | |
| Domain | LMBR1 | 4.06e-04 | 4 | 155 | 2 | PF04791 | |
| Domain | DUF1394 | 4.06e-04 | 4 | 155 | 2 | IPR009828 | |
| Domain | Tribbles/Ser_Thr_kinase_40 | 4.06e-04 | 4 | 155 | 2 | IPR024104 | |
| Domain | DUF1394 | 4.06e-04 | 4 | 155 | 2 | PF07159 | |
| Domain | Pecanex | 4.06e-04 | 4 | 155 | 2 | IPR007735 | |
| Domain | P-type_ATPase_IIB | 4.06e-04 | 4 | 155 | 2 | IPR006408 | |
| Domain | LMBR1-like_membr_prot | 4.06e-04 | 4 | 155 | 2 | IPR006876 | |
| Domain | KCL_cotranspt | 4.06e-04 | 4 | 155 | 2 | IPR000076 | |
| Domain | Cation_ATPase_N | 4.17e-04 | 18 | 155 | 3 | PF00690 | |
| Domain | Cation_ATPase_N | 4.17e-04 | 18 | 155 | 3 | SM00831 | |
| Domain | ATPase_P-typ_cation-transptr_N | 4.93e-04 | 19 | 155 | 3 | IPR004014 | |
| Domain | HAD-like_dom | 5.07e-04 | 79 | 155 | 5 | IPR023214 | |
| Domain | AA-permease/SLC12A_dom | 7.69e-04 | 22 | 155 | 3 | IPR004841 | |
| Domain | AA_permease | 7.69e-04 | 22 | 155 | 3 | PF00324 | |
| Domain | RIH_assoc-dom | 1.00e-03 | 6 | 155 | 2 | IPR013662 | |
| Domain | Ins145_P3_rec | 1.00e-03 | 6 | 155 | 2 | PF08709 | |
| Domain | RIH_assoc | 1.00e-03 | 6 | 155 | 2 | PF08454 | |
| Domain | RIH_dom | 1.00e-03 | 6 | 155 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 1.00e-03 | 6 | 155 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 1.00e-03 | 6 | 155 | 2 | IPR015925 | |
| Domain | - | 1.00e-03 | 6 | 155 | 2 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 1.00e-03 | 6 | 155 | 2 | PF01365 | |
| Domain | IQ | 1.07e-03 | 93 | 155 | 5 | PS50096 | |
| Domain | SLC12A_fam | 1.40e-03 | 7 | 155 | 2 | IPR004842 | |
| Domain | SLC12_C | 1.85e-03 | 8 | 155 | 2 | IPR018491 | |
| Domain | SLC12 | 1.85e-03 | 8 | 155 | 2 | PF03522 | |
| Domain | - | 2.33e-03 | 32 | 155 | 3 | 3.40.1110.10 | |
| Domain | - | 2.33e-03 | 32 | 155 | 3 | 2.70.150.10 | |
| Domain | 7TM_GPCR_Srsx | 2.43e-03 | 112 | 155 | 5 | SM01381 | |
| Domain | IQ | 2.88e-03 | 71 | 155 | 4 | PF00612 | |
| Domain | MIR | 2.95e-03 | 10 | 155 | 2 | PF02815 | |
| Domain | MIR_motif | 2.95e-03 | 10 | 155 | 2 | IPR016093 | |
| Domain | MIR | 2.95e-03 | 10 | 155 | 2 | PS50919 | |
| Domain | MIR | 2.95e-03 | 10 | 155 | 2 | SM00472 | |
| Domain | ANF_lig-bd_rcpt | 3.54e-03 | 37 | 155 | 3 | IPR001828 | |
| Domain | ANF_receptor | 3.54e-03 | 37 | 155 | 3 | PF01094 | |
| Domain | Cation/H_exchanger_CPA1 | 3.58e-03 | 11 | 155 | 2 | IPR018422 | |
| Domain | Peripla_BP_I | 4.12e-03 | 39 | 155 | 3 | IPR028082 | |
| Domain | Na_H_Exchanger | 5.83e-03 | 14 | 155 | 2 | PF00999 | |
| Domain | Cation/H_exchanger | 5.83e-03 | 14 | 155 | 2 | IPR006153 | |
| Domain | 2pore_dom_K_chnl | 6.69e-03 | 15 | 155 | 2 | IPR003280 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC12A6 SLC5A10 TRPC7 ATP13A1 SLC35B3 SLC24A3 SLC7A7 MCOLN1 SLC9C2 SLC1A4 RYR2 SLC5A1 TPCN1 SLC5A3 SLC5A11 SLC6A2 ABCG1 MBTPS2 SLC44A5 SLC22A4 ABCD3 SLC9A7 TRPV3 LRRC8B SLC5A8 ATP12A SLC12A7 ATP2B2 SLC33A1 ATP2B4 | 2.26e-12 | 736 | 128 | 30 | M27287 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC12A6 SLC5A10 TRPC7 ATP13A1 SLC35B3 SLC24A3 SLC7A7 MCOLN1 SLC1A4 RYR2 SLC5A1 TPCN1 SLC5A3 SLC5A11 SLC6A2 ABCG1 SLC44A5 SLC22A4 ABCD3 SLC9A7 TRPV3 LRRC8B SLC5A8 ATP12A SLC12A7 ATP2B2 SLC33A1 ATP2B4 | 1.15e-11 | 681 | 128 | 28 | MM14985 |
| Pathway | REACTOME_CARDIAC_CONDUCTION | CACNA1C SCN11A RYR2 ITPR3 SCN1A SCN2A SCN3A SCN7A SCN8A KCNK10 KCNK2 ATP2B2 ATP2B4 | 1.64e-10 | 130 | 128 | 13 | M27454 |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC12A6 SLC5A10 SLC35B3 SLC24A3 SLC7A7 SLC1A4 SLC5A1 SLC5A3 SLC5A11 SLC6A2 SLC44A5 SLC22A4 SLC9A7 SLC5A8 SLC12A7 SLC33A1 | 4.59e-10 | 238 | 128 | 16 | MM15076 |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC12A6 SLC5A10 SLC35B3 SLC24A3 SLC7A7 SLC1A4 SLC5A1 SLC5A3 SLC5A11 SLC6A2 SLC44A5 SLC22A4 SLC9A7 SLC5A8 SLC12A7 SLC33A1 | 8.90e-10 | 249 | 128 | 16 | M5988 |
| Pathway | REACTOME_SENSORY_PERCEPTION | OR51A4 OR51A2 CACNA1D OR5B3 OR5T3 OR5B2 OR5D14 OR10J3 OR5AN1 OR5T2 OR5A1 OR8U3 LRRC52 ITPR3 OR1D2 OR52I2 OR5J2 TAS2R14 SCN2A SCN3A OR10J4 OR11H2 ATP2B2 OR4C5 | 2.38e-09 | 636 | 128 | 24 | M41834 |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 1.20e-08 | 32 | 128 | 7 | M27455 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | CACNA1C SCN11A RYR2 ITPR3 SCN1A SCN2A SCN3A SCN7A SCN8A KCNK10 KCNK2 ATP2B2 ATP2B4 | 3.86e-08 | 203 | 128 | 13 | M5485 |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_VGCC_CA2_APOPTOTIC_PATHWAY | 9.59e-08 | 6 | 128 | 4 | M47762 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | OR51A4 OR51A2 OR5B3 OR5T3 OR5B2 OR5D14 OR10J3 OR5AN1 OR5T2 OR5A1 OR8U3 OR1D2 OR52I2 OR5J2 OR10J4 OR11H2 OR4C5 | 2.23e-07 | 417 | 128 | 17 | M4072 |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 3.04e-07 | 31 | 128 | 6 | M877 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | CACNA1C CACNA1D CACNA1F CACNA1S ERBB4 CHRM2 RYR2 ITPR3 ATP2B2 ATP2B4 | 5.02e-06 | 178 | 128 | 10 | M2890 |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_VGCC_CA2_APOPTOTIC_PATHWAY_N01004 | 6.05e-06 | 14 | 128 | 4 | M47692 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | TRPC7 ATP13A1 MCOLN1 SLC9C2 RYR2 TPCN1 TRPV3 ATP12A ATP2B2 ATP2B4 | 6.42e-06 | 183 | 128 | 10 | M997 |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 3.21e-05 | 176 | 128 | 9 | MM15718 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 4.15e-05 | 103 | 128 | 7 | MM15196 | |
| Pathway | KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY | 5.02e-05 | 23 | 128 | 4 | M47666 | |
| Pathway | KEGG_OLFACTORY_TRANSDUCTION | OR51A4 OR51A2 OR5B3 OR5T3 OR5D14 OR10J3 OR5AN1 OR5T2 OR5A1 OR8U3 OR1D2 OR52I2 OR5J2 | 5.28e-05 | 389 | 128 | 13 | M14091 |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 5.63e-05 | 108 | 128 | 7 | M823 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 5.97e-05 | 109 | 128 | 7 | MM15074 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL | 7.08e-05 | 25 | 128 | 4 | M47948 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 9.68e-05 | 27 | 128 | 4 | MM15053 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 1.12e-04 | 28 | 128 | 4 | M924 | |
| Pathway | WP_DRAVET_SYNDROME | 1.12e-04 | 28 | 128 | 4 | M45519 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 1.14e-04 | 11 | 128 | 3 | M47958 | |
| Pathway | WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION | 3.05e-04 | 36 | 128 | 4 | M39831 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 3.84e-04 | 147 | 128 | 7 | MM15854 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 4.05e-04 | 106 | 128 | 6 | M27200 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 4.51e-04 | 151 | 128 | 7 | M39329 | |
| Pathway | WP_ADHD_AND_AUTISM_ASD_PATHWAYS | CACNA1C SCN11A SLC6A2 SCN1A SCN2A SCN3A SCN7A SCN8A HTR3B LMBRD1 GABBR1 | 5.14e-04 | 367 | 128 | 11 | M48346 |
| Pathway | KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC | 5.57e-04 | 74 | 128 | 5 | M16376 | |
| Pathway | WP_ALZHEIMERS_DISEASE | 5.57e-04 | 74 | 128 | 5 | MM15962 | |
| Pathway | WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY | 5.57e-04 | 74 | 128 | 5 | M39462 | |
| Pathway | REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS | 6.30e-04 | 76 | 128 | 5 | MM15072 | |
| Pathway | KEGG_CARDIAC_MUSCLE_CONTRACTION | 7.52e-04 | 79 | 128 | 5 | M17673 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 7.65e-04 | 165 | 128 | 7 | MM15026 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_ESPJ_TO_IGG_FCGR_RAC_SIGNALING_PATHWAY | 8.04e-04 | 5 | 128 | 2 | M49014 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 8.17e-04 | 121 | 128 | 6 | M872 | |
| Pathway | REACTOME_SENSORY_PERCEPTION_OF_TASTE | 8.55e-04 | 47 | 128 | 4 | M42524 | |
| Pathway | KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM | 9.41e-04 | 83 | 128 | 5 | M8728 | |
| Pathway | REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS | 9.93e-04 | 84 | 128 | 5 | M27334 | |
| Pathway | KEGG_DILATED_CARDIOMYOPATHY | 1.35e-03 | 90 | 128 | 5 | M835 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 1.44e-03 | 54 | 128 | 4 | M27460 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 1.44e-03 | 54 | 128 | 4 | MM15202 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 1.55e-03 | 55 | 128 | 4 | M971 | |
| Pathway | REACTOME_CATION_COUPLED_CHLORIDE_COTRANSPORTERS | 1.67e-03 | 7 | 128 | 2 | M27339 | |
| Pathway | REACTOME_CATION_COUPLED_CHLORIDE_COTRANSPORTERS | 1.67e-03 | 7 | 128 | 2 | MM15081 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 1.77e-03 | 57 | 128 | 4 | MM15643 | |
| Pathway | WP_NRF2_PATHWAY | 1.80e-03 | 141 | 128 | 6 | M39454 | |
| Pathway | REACTOME_TRP_CHANNELS | 2.03e-03 | 28 | 128 | 3 | MM14943 | |
| Pathway | REACTOME_TRP_CHANNELS | 2.03e-03 | 28 | 128 | 3 | M27241 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 2.07e-03 | 99 | 128 | 5 | MM14910 | |
| Pathway | REACTOME_SLC_TRANSPORTER_DISORDERS | 2.07e-03 | 99 | 128 | 5 | M27474 | |
| Pathway | WP_DISORDERS_OF_BILE_ACID_SYNTHESIS_AND_BILIARY_TRANSPORT | 2.25e-03 | 29 | 128 | 3 | M45551 | |
| Pathway | KEGG_GNRH_SIGNALING_PATHWAY | 2.25e-03 | 101 | 128 | 5 | M1979 | |
| Pathway | WP_ALZHEIMERS_DISEASE | 2.62e-03 | 261 | 128 | 8 | M42565 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 2.66e-03 | 205 | 128 | 7 | M752 | |
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | CACNA1C CACNA1D CACNA1F CACNA1S SCN11A RYR2 KCNQ5 SCN1A SCN3A SCN7A SCN8A KCNK2 | 2.38e-12 | 139 | 160 | 12 | 16985003 |
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 7.31e-12 | 38 | 160 | 8 | 30786075 | |
| Pubmed | 2.40e-10 | 9 | 160 | 5 | 16382098 | ||
| Pubmed | 4.31e-10 | 4 | 160 | 4 | 17537961 | ||
| Pubmed | 4.31e-10 | 4 | 160 | 4 | 20937870 | ||
| Pubmed | 4.31e-10 | 4 | 160 | 4 | 35031483 | ||
| Pubmed | 4.31e-10 | 4 | 160 | 4 | 29578003 | ||
| Pubmed | A 'toothache tree' alkylamide inhibits Aδ mechanonociceptors to alleviate mechanical pain. | 6.42e-09 | 6 | 160 | 4 | 23652591 | |
| Pubmed | Different evolutionary processes shaped the mouse and human olfactory receptor gene families. | OR5B3 OR5T3 OR5B2 OR5D14 OR10J3 OR5AN1 OR5T2 OR5A1 OR8U3 OR1D2 OR52I2 OR5J2 OR4C5 | 7.16e-09 | 340 | 160 | 13 | 11875048 |
| Pubmed | OR5B3 OR5T3 OR5B2 OR5D14 OR10J3 OR5AN1 OR5T2 OR5A1 OR8U3 OR1D2 OR52I2 OR5J2 OR4C5 | 7.16e-09 | 340 | 160 | 13 | 11802173 | |
| Pubmed | OR5B3 OR5T3 OR5B2 OR5D14 OR10J3 OR5AN1 OR5T2 OR5A1 OR8U3 OR1D2 OR52I2 OR5J2 OR4C5 | 7.95e-09 | 343 | 160 | 13 | 32295537 | |
| Pubmed | OR5B3 OR5T3 OR5B2 OR5D14 OR10J3 OR5AN1 OR5T2 OR5A1 OR8U3 OR1D2 OR52I2 OR5J2 OR4C5 | 8.81e-09 | 346 | 160 | 13 | 14611657 | |
| Pubmed | 1.49e-08 | 7 | 160 | 4 | 12900400 | ||
| Pubmed | 5.34e-08 | 9 | 160 | 4 | 15746173 | ||
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 1825220 | ||
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 23859570 | ||
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 17767505 | ||
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 2173707 | ||
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 17289261 | ||
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 12610651 | ||
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 18784617 | ||
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 17544618 | ||
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 32845893 | ||
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 28518218 | ||
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 17928448 | ||
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 14973256 | ||
| Pubmed | Systematic protein-protein interaction mapping for clinically relevant human GPCRs. | SPNS1 ATP13A1 RTN4 LAPTM4B GRIK1 PIGG MCOLN1 CHRM2 SLC1A4 CYFIP2 NISCH SLC9A7 CCR1 CCR6 SARAF GABBR1 | 1.60e-07 | 697 | 160 | 16 | 28298427 |
| Pubmed | Nav1.2 haplodeficiency in excitatory neurons causes absence-like seizures in mice. | 2.07e-07 | 12 | 160 | 4 | 30175250 | |
| Pubmed | OR5B3 OR5T3 OR5B2 OR5D14 OR10J3 OR5AN1 OR5T2 OR5A1 OR8U3 OR1D2 OR52I2 OR5J2 OR11H2 OR4C5 | 2.38e-07 | 541 | 160 | 14 | 14983052 | |
| Pubmed | 2.99e-07 | 13 | 160 | 4 | 15123669 | ||
| Pubmed | 3.81e-07 | 4 | 160 | 3 | 35801810 | ||
| Pubmed | 3.81e-07 | 4 | 160 | 3 | 21156207 | ||
| Pubmed | Use of recombinant inbred strains for studying genetic determinants of responses to alcohol. | 3.81e-07 | 4 | 160 | 3 | 8974318 | |
| Pubmed | 5.66e-07 | 15 | 160 | 4 | 20188150 | ||
| Pubmed | Confirmation of quantitative trait loci for alcohol preference in mice. | 5.66e-07 | 15 | 160 | 4 | 9726281 | |
| Pubmed | 5.66e-07 | 15 | 160 | 4 | 24453333 | ||
| Pubmed | Interactome Analysis of Human Phospholipase D and Phosphatidic Acid-Associated Protein Network. | GPR89B SPNS1 RTN4 SRPRA LMBRD2 AP3M1 ACSL1 ATP12A SLC33A1 ATP2B4 | 8.18e-07 | 282 | 160 | 10 | 35007762 |
| Pubmed | 9.49e-07 | 5 | 160 | 3 | 1679748 | ||
| Pubmed | 9.49e-07 | 5 | 160 | 3 | 8812438 | ||
| Pubmed | Early development of electrical excitability in the mouse enteric nervous system. | 9.49e-07 | 5 | 160 | 3 | 22875929 | |
| Pubmed | 9.49e-07 | 5 | 160 | 3 | 24337656 | ||
| Pubmed | 9.49e-07 | 5 | 160 | 3 | 17724025 | ||
| Pubmed | 9.49e-07 | 5 | 160 | 3 | 31663850 | ||
| Pubmed | 9.49e-07 | 5 | 160 | 3 | 24595108 | ||
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | TMEM41A SLC38A9 PIGG LMBRD2 SLC7A7 MCOLN1 SLC1A4 ANAPC2 SLC9A7 SARAF TMEM164 SLC12A7 SLC33A1 ATP2B4 RNF182 | 1.31e-06 | 719 | 160 | 15 | 35337019 |
| Pubmed | 1.70e-06 | 176 | 160 | 8 | 28692057 | ||
| Pubmed | Are voltage-dependent ion channels involved in the endothelial cell control of vasomotor tone? | 1.89e-06 | 6 | 160 | 3 | 17513486 | |
| Pubmed | 1.89e-06 | 6 | 160 | 3 | 23711479 | ||
| Pubmed | 1.89e-06 | 6 | 160 | 3 | 16352659 | ||
| Pubmed | 1.89e-06 | 6 | 160 | 3 | 22502635 | ||
| Pubmed | 3.30e-06 | 7 | 160 | 3 | 18209093 | ||
| Pubmed | Diagnostic yield of genetic testing in epileptic encephalopathy in childhood. | 3.30e-06 | 7 | 160 | 3 | 25818041 | |
| Pubmed | SLC12A6 DNAJC16 RTN4 SRPRA ITPR3 NISCH VPS13A ABCD3 GPR89A SLC12A7 SLC33A1 DOP1B | 4.18e-06 | 504 | 160 | 12 | 34432599 | |
| Pubmed | 4.73e-06 | 143 | 160 | 7 | 20424473 | ||
| Pubmed | 5.26e-06 | 8 | 160 | 3 | 28330839 | ||
| Pubmed | Fcγ receptor-mediated inflammation inhibits axon regeneration. | 7.87e-06 | 9 | 160 | 3 | 24523933 | |
| Pubmed | 7.87e-06 | 9 | 160 | 3 | 16382099 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | PDE3B RPN1 ATP13A1 DNAJC16 RTN4 SRPRA AP3M1 ITPR3 TIMM21 NISCH ANAPC2 ABCD3 SARAF SLC33A1 ATP2B4 XPOT | 7.92e-06 | 942 | 160 | 16 | 31073040 |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | SLC12A6 SPNS1 TMEM41A ATP13A1 EML4 RTN4 SRPRA LMBRD2 HARS2 VPS13A GPR89A TMEM164 ATP12A SLC12A7 SLC33A1 ATP2B4 XPOT | 8.71e-06 | 1061 | 160 | 17 | 33845483 |
| Pubmed | PDE3B EML4 DNAJC16 RTN4 SRPRA LMBRD2 NISCH SLC22A4 ANAPC2 ABCD3 PPIP5K2 SLC12A7 SLC33A1 | 1.07e-05 | 650 | 160 | 13 | 38777146 | |
| Pubmed | FAM105A/OTULINL Is a Pseudodeubiquitinase of the OTU-Class that Localizes to the ER Membrane. | PDE3B RPN1 ATP13A1 DNAJC16 RTN4 SRPRA ITPR3 VPS13A GPR89A SYVN1 SLC33A1 | 1.20e-05 | 468 | 160 | 11 | 31056421 |
| Pubmed | 1.53e-05 | 11 | 160 | 3 | 18809727 | ||
| Pubmed | 2.04e-05 | 12 | 160 | 3 | 31801071 | ||
| Pubmed | 2.04e-05 | 12 | 160 | 3 | 8169823 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 2521732 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 25277766 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 15673679 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 35809272 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 20346423 | ||
| Pubmed | Reduction of Kcnt1 is therapeutic in mouse models of SCN1A and SCN8A epilepsy. | 2.10e-05 | 2 | 160 | 2 | 37901435 | |
| Pubmed | Novel mutations in 5-HT3A and 5-HT3B receptor genes not associated with clozapine response. | 2.10e-05 | 2 | 160 | 2 | 12363396 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 23054685 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 19840997 | ||
| Pubmed | An Scn1a epilepsy mutation in Scn8a alters seizure susceptibility and behavior. | 2.10e-05 | 2 | 160 | 2 | 26410685 | |
| Pubmed | Co-association of CD3 zeta with a receptor (CD16) for IgG Fc on human natural killer cells. | 2.10e-05 | 2 | 160 | 2 | 2532305 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 25168769 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 23786674 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 11182092 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 19741568 | ||
| Pubmed | Neuronal death and perinatal lethality in voltage-gated sodium channel alpha(II)-deficient mice. | 2.10e-05 | 2 | 160 | 2 | 10827969 | |
| Pubmed | Single-cell analyses identify dysfunctional CD16+ CD8 T cells in smokers. | 2.10e-05 | 2 | 160 | 2 | 33163982 | |
| Pubmed | Demonstration of 5-HT(3) receptor function and expression in the mouse bladder. | 2.10e-05 | 2 | 160 | 2 | 17607564 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 21887366 | ||
| Pubmed | Different dysregulations of CYFIP1 and CYFIP2 in distinct types of dementia. | 2.10e-05 | 2 | 160 | 2 | 38128786 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 19694741 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 35348308 | ||
| Pubmed | Genomic structures of SCN2A and SCN3A - candidate genes for deafness at the DFNA16 locus. | 2.10e-05 | 2 | 160 | 2 | 11245985 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 1281468 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 14724198 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 15539395 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 26494566 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 21054386 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 12750374 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 15760941 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 19185213 | ||
| Pubmed | Differential expression of two sodium channel subtypes in human brain. | 2.10e-05 | 2 | 160 | 2 | 1317301 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 9342215 | ||
| Pubmed | Duplication of the sodium channel gene cluster on 2q24 in children with early onset epilepsy. | 2.10e-05 | 2 | 160 | 2 | 23016767 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 23917248 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 7696618 | ||
| Interaction | CCR6 interactions | ATP13A1 PIGG LMBRD2 MCOLN1 ITPR3 GPR89A CCR6 ATP12A ATP2B2 ATP2B4 | 6.47e-10 | 89 | 141 | 10 | int:CCR6 |
| Interaction | NIPAL1 interactions | ATP13A1 SRPRA LMBRD2 SLC1A4 TPCN1 GPR89A FAM3C ATP12A ATP2B2 ATP2B4 | 7.47e-09 | 114 | 141 | 10 | int:NIPAL1 |
| Interaction | SCN11A interactions | 4.43e-08 | 15 | 141 | 5 | int:SCN11A | |
| Interaction | TTYH1 interactions | SLC12A6 PDE3B PCNX3 LMBRD2 TPCN1 SLC5A3 SLC44A5 GPR89A LRRC8B TMEM164 SLC12A7 ATP2B2 ATP2B4 | 1.96e-07 | 300 | 141 | 13 | int:TTYH1 |
| Interaction | LNPK interactions | PITPNM2 PDE3B RPN1 DNAJC16 RTN4 SRPRA AP3M1 CYFIP2 ITPR3 GJD3 SLC5A8 SLC51A SLC33A1 GABBR1 | 2.06e-07 | 355 | 141 | 14 | int:LNPK |
| Interaction | SCN9A interactions | 2.90e-07 | 21 | 141 | 5 | int:SCN9A | |
| Interaction | KIR2DL4 interactions | 3.15e-07 | 94 | 141 | 8 | int:KIR2DL4 | |
| Interaction | FPR2 interactions | 5.55e-07 | 138 | 141 | 9 | int:FPR2 | |
| Interaction | CACNA1D interactions | 5.96e-07 | 24 | 141 | 5 | int:CACNA1D | |
| Interaction | TMEM63A interactions | 6.39e-07 | 103 | 141 | 8 | int:TMEM63A | |
| Interaction | GPR182 interactions | SPNS1 SRPRA PIGG LMBRD2 CYFIP2 SLC5A3 ACSL1 ABCD3 GPR89A TMEM164 ATP12A ATP2B2 SLC33A1 DOP1B XPOT | 7.30e-07 | 455 | 141 | 15 | int:GPR182 |
| Interaction | SCN5A interactions | 8.94e-07 | 47 | 141 | 6 | int:SCN5A | |
| Interaction | PLD3 interactions | GPR89B SPNS1 RPN1 RTN4 SRPRA LMBRD2 ACSL1 GJD3 ATP12A SLC33A1 ATP2B4 | 1.31e-06 | 246 | 141 | 11 | int:PLD3 |
| Interaction | C5AR1 interactions | SLC38A9 LMBRD2 TPCN1 SLC5A3 GPR89A TMEM164 ATP12A ATP2B2 ATP2B4 | 1.39e-06 | 154 | 141 | 9 | int:C5AR1 |
| Interaction | GPR89A interactions | 2.04e-06 | 120 | 141 | 8 | int:GPR89A | |
| Interaction | SEC62 interactions | SLC12A6 PDE3B RPN1 ATP13A1 DNAJC16 RTN4 SRPRA SERINC2 CYFIP2 ITPR3 VPS13A GPR89A FAM3C ATP12A SLC33A1 | 2.72e-06 | 506 | 141 | 15 | int:SEC62 |
| Interaction | GPR17 interactions | SLC38A9 PIGG LMBRD2 TPCN1 SLC5A3 GPR89A TMEM164 ATP12A SLC33A1 ATP2B4 XPOT | 5.05e-06 | 283 | 141 | 11 | int:GPR17 |
| Interaction | HTR3A interactions | 1.09e-05 | 108 | 141 | 7 | int:HTR3A | |
| Interaction | GRIA2 interactions | 1.33e-05 | 203 | 141 | 9 | int:GRIA2 | |
| Interaction | SLC22A15 interactions | 1.52e-05 | 22 | 141 | 4 | int:SLC22A15 | |
| Interaction | TACR3 interactions | 1.54e-05 | 76 | 141 | 6 | int:TACR3 | |
| Interaction | HSD3B7 interactions | PDE3B RPN1 ATP13A1 SLC38A9 DNAJC16 RTN4 SRPRA ITPR3 VPS13A ABCD3 GPR89A SLC33A1 | 1.78e-05 | 386 | 141 | 12 | int:HSD3B7 |
| Interaction | SCN4B interactions | 1.83e-05 | 8 | 141 | 3 | int:SCN4B | |
| Interaction | OR10S1 interactions | 1.83e-05 | 8 | 141 | 3 | int:OR10S1 | |
| Interaction | RHOG interactions | SLC12A6 PDE3B PCNX3 RPN1 RTN4 SRPRA CYFIP2 ITPR3 HARS2 CYFIP1 NISCH SLC22A4 VPS13A ABCD3 GPR89A CCR1 SLC12A7 SLC33A1 XPOT | 1.98e-05 | 910 | 141 | 19 | int:RHOG |
| Interaction | CA9 interactions | 2.10e-05 | 215 | 141 | 9 | int:CA9 | |
| Interaction | TSPAN15 interactions | HTR3A PCNX3 ATP13A1 RTN4 PIGG TPCN1 SLC22A4 GPR89A CCR6 TMEM164 | 2.52e-05 | 276 | 141 | 10 | int:TSPAN15 |
| Interaction | TPST2 interactions | 2.69e-05 | 124 | 141 | 7 | int:TPST2 | |
| Interaction | GPR173 interactions | 2.83e-05 | 51 | 141 | 5 | int:GPR173 | |
| Interaction | DNAJC25 interactions | GPR89B PDE3B RPN1 ATP13A1 DNAJC16 RTN4 SRPRA ITPR3 VPS13A SLC33A1 | 3.21e-05 | 284 | 141 | 10 | int:DNAJC25 |
| Interaction | SEC63 interactions | SPNS1 PDE3B RPN1 ATP13A1 DNAJC16 RTN4 SRPRA ITPR3 GJD3 ABCD3 SYVN1 | 3.46e-05 | 348 | 141 | 11 | int:SEC63 |
| Interaction | P2RY8 interactions | 3.84e-05 | 179 | 141 | 8 | int:P2RY8 | |
| Interaction | SPPL2B interactions | 3.94e-05 | 233 | 141 | 9 | int:SPPL2B | |
| Interaction | RXFP1 interactions | 4.05e-05 | 90 | 141 | 6 | int:RXFP1 | |
| Interaction | TMT1A interactions | PDE3B RPN1 ATP13A1 DNAJC16 RTN4 SRPRA ITPR3 KCNQ5 VPS13A ABCD3 SLC33A1 | 4.59e-05 | 359 | 141 | 11 | int:TMT1A |
| Interaction | HLA-DQA1 interactions | 4.64e-05 | 135 | 141 | 7 | int:HLA-DQA1 | |
| Interaction | LRRC8D interactions | 4.76e-05 | 29 | 141 | 4 | int:LRRC8D | |
| Interaction | SCN1A interactions | 4.76e-05 | 29 | 141 | 4 | int:SCN1A | |
| Interaction | AQP3 interactions | 4.80e-05 | 239 | 141 | 9 | int:AQP3 | |
| Interaction | CMTM5 interactions | 4.80e-05 | 239 | 141 | 9 | int:CMTM5 | |
| Interaction | BSCL2 interactions | 5.04e-05 | 186 | 141 | 8 | int:BSCL2 | |
| Interaction | SCN10A interactions | 5.31e-05 | 11 | 141 | 3 | int:SCN10A | |
| Interaction | DHRS7 interactions | 5.59e-05 | 139 | 141 | 7 | int:DHRS7 | |
| Interaction | SIDT2 interactions | 5.85e-05 | 140 | 141 | 7 | int:SIDT2 | |
| Interaction | C3orf52 interactions | SLC12A6 PDE3B PCNX3 ATP13A1 SRPRA TPCN1 ITPR3 KCNQ5 SLC12A7 ATP2B4 | 5.86e-05 | 305 | 141 | 10 | int:C3orf52 |
| Interaction | CACNA1C interactions | 6.78e-05 | 61 | 141 | 5 | int:CACNA1C | |
| Interaction | VIPR2 interactions | 6.78e-05 | 194 | 141 | 8 | int:VIPR2 | |
| Interaction | ADGRG2 interactions | 7.04e-05 | 12 | 141 | 3 | int:ADGRG2 | |
| Interaction | CLEC2D interactions | 7.55e-05 | 197 | 141 | 8 | int:CLEC2D | |
| Interaction | RAB9A interactions | PDE3B RPN1 SLC38A9 RTN4 SRPRA ITPR3 NISCH VPS13A ABCD3 SLC12A7 SLC33A1 ATP2B4 DOP1B XPOT | 7.59e-05 | 595 | 141 | 14 | int:RAB9A |
| Interaction | ATP2B2 interactions | 7.82e-05 | 198 | 141 | 8 | int:ATP2B2 | |
| Interaction | APCS interactions | 8.02e-05 | 33 | 141 | 4 | int:APCS | |
| Interaction | OPRL1 interactions | 8.18e-05 | 102 | 141 | 6 | int:OPRL1 | |
| Interaction | GJD3 interactions | PDE3B RPN1 ATP13A1 DNAJC16 RTN4 SRPRA SLC5A3 ITPR3 NISCH GJD3 SLC12A7 SLC33A1 | 8.55e-05 | 454 | 141 | 12 | int:GJD3 |
| Interaction | CERS6 interactions | 9.11e-05 | 104 | 141 | 6 | int:CERS6 | |
| Interaction | STIM1 interactions | PDE3B RPN1 DNAJC16 RTN4 SRPRA ITPR3 GJD3 SLC22A4 SYVN1 SLC33A1 ATP2B4 | 9.20e-05 | 388 | 141 | 11 | int:STIM1 |
| Interaction | PIGO interactions | 9.20e-05 | 65 | 141 | 5 | int:PIGO | |
| Interaction | CYP2C9 interactions | 9.61e-05 | 105 | 141 | 6 | int:CYP2C9 | |
| Interaction | HSD17B11 interactions | PDE3B RPN1 ATP13A1 DNAJC16 RTN4 SRPRA ITPR3 VPS13A ABCD3 GPR89A SLC33A1 | 9.62e-05 | 390 | 141 | 11 | int:HSD17B11 |
| Interaction | LGALS9C interactions | 1.02e-04 | 35 | 141 | 4 | int:LGALS9C | |
| Interaction | SLC41A3 interactions | 1.14e-04 | 36 | 141 | 4 | int:SLC41A3 | |
| Interaction | NALCN interactions | 1.15e-04 | 14 | 141 | 3 | int:NALCN | |
| Interaction | APLNR interactions | 1.22e-04 | 211 | 141 | 8 | int:APLNR | |
| Interaction | GCGR interactions | 1.24e-04 | 110 | 141 | 6 | int:GCGR | |
| Interaction | CACNA1B interactions | 1.27e-04 | 37 | 141 | 4 | int:CACNA1B | |
| Interaction | TMEM17 interactions | SLC12A6 SLC35B3 SRPRA AP3M1 SLC1A4 SLC5A3 CYFIP1 GPR89A SLC12A7 SLC33A1 ATP2B4 | 1.31e-04 | 404 | 141 | 11 | int:TMEM17 |
| Interaction | NUP155 interactions | PDE3B ATP13A1 RTN4 SRPRA AP3M1 ITPR3 GJD3 ABCD3 GPR89A C3 SYVN1 SLC33A1 | 1.36e-04 | 477 | 141 | 12 | int:NUP155 |
| Interaction | MARCHF4 interactions | 1.37e-04 | 112 | 141 | 6 | int:MARCHF4 | |
| Interaction | P2RY2 interactions | 1.37e-04 | 112 | 141 | 6 | int:P2RY2 | |
| Interaction | HSD17B6 interactions | 1.43e-04 | 15 | 141 | 3 | int:HSD17B6 | |
| Interaction | CRELD1 interactions | 1.52e-04 | 163 | 141 | 7 | int:CRELD1 | |
| Interaction | MS4A15 interactions | 1.56e-04 | 39 | 141 | 4 | int:MS4A15 | |
| Interaction | HCRTR2 interactions | 1.56e-04 | 39 | 141 | 4 | int:HCRTR2 | |
| Interaction | LAMP3 interactions | RPN1 ATP13A1 SLC38A9 SRPRA SLC5A3 ITPR3 HARS2 KCNQ5 NISCH GPR89A SLC33A1 DOP1B | 1.62e-04 | 486 | 141 | 12 | int:LAMP3 |
| Interaction | PXMP2 interactions | 1.65e-04 | 281 | 141 | 9 | int:PXMP2 | |
| Interaction | GPR88 interactions | 1.76e-04 | 16 | 141 | 3 | int:GPR88 | |
| Interaction | ATP2A1 interactions | PDE3B RPN1 ATP13A1 DNAJC16 RTN4 SRPRA ITPR3 ABCD3 GPR89A SLC33A1 ATP2B4 | 1.96e-04 | 423 | 141 | 11 | int:ATP2A1 |
| Interaction | DHFR2 interactions | 2.03e-04 | 289 | 141 | 9 | int:DHFR2 | |
| Interaction | SLC4A8 interactions | 2.09e-04 | 42 | 141 | 4 | int:SLC4A8 | |
| Interaction | SRI interactions | 2.19e-04 | 78 | 141 | 5 | int:SRI | |
| Interaction | GJA1 interactions | ERBB4 HTR3A PCNX3 RPN1 SRPRA CYFIP2 ITPR3 NISCH GJD3 VPS13A C3 SLC12A7 ATP2B4 | 2.34e-04 | 583 | 141 | 13 | int:GJA1 |
| Interaction | UBXN8 interactions | 2.46e-04 | 80 | 141 | 5 | int:UBXN8 | |
| Interaction | LPCAT3 interactions | 2.46e-04 | 80 | 141 | 5 | int:LPCAT3 | |
| Interaction | KCNA2 interactions | 2.50e-04 | 125 | 141 | 6 | int:KCNA2 | |
| Interaction | OR2G6 interactions | 2.53e-04 | 18 | 141 | 3 | int:OR2G6 | |
| Interaction | VSIG4 interactions | 2.79e-04 | 180 | 141 | 7 | int:VSIG4 | |
| Interaction | HLA-B interactions | 2.84e-04 | 239 | 141 | 8 | int:HLA-B | |
| Interaction | REEP5 interactions | PDE3B RPN1 ATP13A1 RTN4 SRPRA ITPR3 GJD3 VPS13A FAM3C SLC33A1 | 2.89e-04 | 371 | 141 | 10 | int:REEP5 |
| Interaction | LRRC52 interactions | 3.50e-04 | 20 | 141 | 3 | int:LRRC52 | |
| Interaction | RXYLT1 interactions | 3.50e-04 | 20 | 141 | 3 | int:RXYLT1 | |
| Interaction | SLC24A3 interactions | 3.50e-04 | 20 | 141 | 3 | int:SLC24A3 | |
| Interaction | DERL1 interactions | CACNA1C PDE3B RPN1 ATP13A1 DNAJC16 RTN4 SRPRA ITPR3 SYVN1 SLC33A1 ATP2B4 | 3.51e-04 | 453 | 141 | 11 | int:DERL1 |
| Interaction | SSR1 interactions | PDE3B RPN1 ATP13A1 DNAJC16 RTN4 SRPRA ITPR3 KCNQ5 GJD3 VPS13A SLC33A1 | 3.51e-04 | 453 | 141 | 11 | int:SSR1 |
| Interaction | CYB5A interactions | 3.63e-04 | 134 | 141 | 6 | int:CYB5A | |
| Interaction | RAB4A interactions | SLC12A6 RTN4 SRPRA ITPR3 NISCH VPS13A ABCD3 SLC9A7 SLC12A7 SLC33A1 DOP1B | 3.78e-04 | 457 | 141 | 11 | int:RAB4A |
| Interaction | NAT8B interactions | 4.07e-04 | 21 | 141 | 3 | int:NAT8B | |
| Interaction | CAMLG interactions | 4.42e-04 | 139 | 141 | 6 | int:CAMLG | |
| Interaction | DIO3 interactions | 4.68e-04 | 22 | 141 | 3 | int:DIO3 | |
| Interaction | SYVN1 interactions | 4.69e-04 | 324 | 141 | 9 | int:SYVN1 | |
| Interaction | GPR12 interactions | 4.95e-04 | 93 | 141 | 5 | int:GPR12 | |
| Cytoband | 11q12.1 | 1.70e-06 | 161 | 160 | 7 | 11q12.1 | |
| Cytoband | 2q24.3 | 2.25e-05 | 16 | 160 | 3 | 2q24.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q12 | 3.11e-05 | 345 | 160 | 8 | chr11q12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q24 | 8.72e-05 | 127 | 160 | 5 | chr2q24 | |
| GeneFamily | Solute carriers | SLC12A6 SLC5A10 SLC38A9 SLC35B3 SLC24A3 SLC7A7 SLC9C2 SLC1A4 SLC5A1 SLC35F4 SLC5A3 SLC5A11 SLC6A2 SLC44A5 SLC10A5 SLC22A4 SLC9A7 SLC38A11 SLC5A8 SLC51A SLC12A7 SLC33A1 | 1.22e-14 | 395 | 119 | 22 | 752 |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 1.40e-09 | 9 | 119 | 5 | 1203 | |
| GeneFamily | Olfactory receptors, family 5 | 5.32e-08 | 112 | 119 | 9 | 152 | |
| GeneFamily | Calcium voltage-gated channel subunits | 2.38e-05 | 26 | 119 | 4 | 253 | |
| GeneFamily | CD molecules|C-C motif chemokine receptors | 3.23e-05 | 10 | 119 | 3 | 1091 | |
| GeneFamily | Glutamate ionotropic receptor kainate type subunits | 4.24e-04 | 5 | 119 | 2 | 1199 | |
| GeneFamily | 5-hydroxytryptamine receptors, ionotropic | 4.24e-04 | 5 | 119 | 2 | 172 | |
| GeneFamily | Transient receptor potential cation channels | 8.08e-04 | 28 | 119 | 3 | 249 | |
| GeneFamily | ATPases Ca2+ transporting | 1.50e-03 | 9 | 119 | 2 | 1209 | |
| GeneFamily | Potassium two pore domain channel subfamily K | 4.26e-03 | 15 | 119 | 2 | 277 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | DOCK3 CACNA1C DNAJC16 RTN4 SLC24A3 GRIK1 GRIK2 RYR2 CYFIP2 SLC5A3 SCN1A SCN2A SLC22A4 SCN3A SCN8A KCNK2 SLC9A7 SORCS3 ATP2B2 DOP1B | 8.86e-06 | 1106 | 155 | 20 | M39071 |
| Coexpression | MIKKELSEN_MCV6_HCP_WITH_H3K27ME3 | DOCK3 CACNA1D COL15A1 WNT7B SERINC2 SIM2 PGAP6 PCNX2 SLC6A2 CORO2B SCN8A ATP2B2 | 1.23e-05 | 438 | 155 | 12 | M1954 |
| Coexpression | MIKKELSEN_MCV6_HCP_WITH_H3K27ME3 | DOCK3 CACNA1D COL15A1 WNT7B SERINC2 SIM2 PGAP6 PCNX2 SLC6A2 CORO2B SCN8A ATP2B2 | 1.29e-05 | 440 | 155 | 12 | MM832 |
| Coexpression | GSE37605_C57BL6_VS_NOD_FOXP3_IRES_GFP_TCONV_UP | 2.36e-05 | 143 | 155 | 7 | M8819 | |
| CoexpressionAtlas | kidney single cell_adult_RenalCortexMixed_StemCellamp_k-means-cluster#1_top-relative-expression-ranked_1000 | SLC5A10 SLC35B3 CD164 SRPRA SLC7A7 PGAP6 SLC5A1 SLC5A11 ACSL1 MINDY3 TIMM21 SLC22A4 CYP7B1 SARAF SLC5A8 SLC51A LMBRD1 SLC33A1 | 1.13e-05 | 831 | 142 | 18 | gudmap_kidney single cell_adult_RenalCortexMixed_Scamp_k1_1000 |
| CoexpressionAtlas | kidney single cell_adult_RenalCortexMixed_StemCellamp_top-relative-expression-ranked_1000 | SLC5A10 SLC35B3 CD164 SRPRA SLC7A7 PGAP6 SLC5A1 SLC5A11 ACSL1 MINDY3 TIMM21 SLC22A4 CYP7B1 SARAF SLC5A8 SLC51A LMBRD1 SLC33A1 | 2.70e-05 | 887 | 142 | 18 | gudmap_kidney single cell_adult_RenalCortexMixed_Scamp_1000 |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | CACNA1C CACNA1D GRIK2 RYR2 KCNQ5 SLC44A5 SCN1A SCN2A SCN3A SCN8A ATP2B2 | 1.49e-10 | 198 | 159 | 11 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | ERBB4 WNT7B OVOS2 SLC24A3 GRIK1 GRIK2 CHRM2 SLC35F4 SCN7A SORCS3 | 1.51e-09 | 187 | 159 | 10 | d2ffb2f34f07b0dd5d3cb3ee0275f46ebecf4146 |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | CACNA1C CACNA1D GRIK2 RYR2 KCNQ5 SCN1A SCN2A SCN3A SCN8A ATP2B2 | 2.62e-09 | 198 | 159 | 10 | c01091ef18e096d792ea2a7a715764a5b215355f |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | CACNA1C CACNA1D GRIK2 RYR2 KCNQ5 SCN1A SCN2A SCN3A SCN8A ATP2B2 | 2.62e-09 | 198 | 159 | 10 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.33e-08 | 193 | 159 | 9 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.33e-08 | 193 | 159 | 9 | 0c652ebe22ce5d2927599dd97ef1920547858395 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.33e-08 | 193 | 159 | 9 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.81e-08 | 196 | 159 | 9 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.15e-08 | 198 | 159 | 9 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA-|Macroglial / cells hierarchy compared to all cells using T-Statistic | CACNA1D SLC24A3 GRIK1 GRIK2 SLC44A5 SCN1A SCN2A SCN3A SORCS3 | 4.53e-08 | 200 | 159 | 9 | f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2 |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA--|Macroglial / cells hierarchy compared to all cells using T-Statistic | CACNA1D SLC24A3 GRIK1 GRIK2 SLC44A5 SCN1A SCN2A SCN3A SORCS3 | 4.53e-08 | 200 | 159 | 9 | cc3409518f8b436ea92deb955e81114b3f410ff7 |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 4.53e-08 | 200 | 159 | 9 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA|Macroglial / cells hierarchy compared to all cells using T-Statistic | CACNA1D SLC24A3 GRIK1 GRIK2 SLC44A5 SCN1A SCN2A SCN3A SORCS3 | 4.53e-08 | 200 | 159 | 9 | c24a3099e3d96d8b72f6d05286bb355d661a0377 |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA---|Macroglial / cells hierarchy compared to all cells using T-Statistic | CACNA1D SLC24A3 GRIK1 GRIK2 SLC44A5 SCN1A SCN2A SCN3A SORCS3 | 4.53e-08 | 200 | 159 | 9 | 4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | CACNA1D SLC24A3 GRIK1 GRIK2 SLC44A5 SCN1A SCN2A SCN3A SORCS3 | 4.53e-08 | 200 | 159 | 9 | 310cd53db1c137f6af74e6ae682221d7ac27310c |
| ToppCell | Macroglial-Polydendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | CACNA1D SLC24A3 GRIK1 GRIK2 SLC44A5 SCN1A SCN2A SCN3A SORCS3 | 4.53e-08 | 200 | 159 | 9 | 961858738ce35db8760c8c2e136f8369bc444ccf |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.61e-07 | 178 | 159 | 8 | 2a36475c260088f69f3b8c282d910e5eaa5c5c2d | |
| ToppCell | PCW_13-14-Neuronal-Neuronal_postreplicative-neuro_neuronal_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.73e-07 | 179 | 159 | 8 | af0b54c9ea0b6e4210f22dbb6e88ecd3276a5f86 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.09e-07 | 182 | 159 | 8 | e1e58176f533092b6b974ca1ce8b02192a6e193d | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.09e-07 | 182 | 159 | 8 | d3a037268f026eb2f84428b1821022503cef7756 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.09e-07 | 182 | 159 | 8 | 57bb5a2da976464ba7c4460106bd9f692008ebd9 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.50e-07 | 185 | 159 | 8 | 16e9ccea0e3b95d90dc48ef74206c805681dac0b | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.50e-07 | 185 | 159 | 8 | 79cff4f3c6ae8e5ea60e8eae082b9275f2679ee9 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 3.96e-07 | 188 | 159 | 8 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.65e-07 | 192 | 159 | 8 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.86e-07 | 198 | 159 | 8 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6-CDH12|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.33e-07 | 200 | 159 | 8 | c74bc12e13d002dedaaf75a2244ec111e47524e1 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6-CDH12-L1-2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.33e-07 | 200 | 159 | 8 | ead9eb579bb25fde05fc15602e3d05ab6617f7ac | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.33e-07 | 200 | 159 | 8 | 8a8f9d9e5ffab3f736c4bd0a5bb616d442d137d1 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lmo1_Myl1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.83e-07 | 144 | 159 | 7 | 0322fef818a963be00535d5f141f028d43de5c6a | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.27e-06 | 152 | 159 | 7 | 8ff5a178a8f3550d89a003c0858820aab3773386 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.36e-06 | 176 | 159 | 7 | 1595dbeee336a81e581325d63208ec6262664ee9 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.49e-06 | 177 | 159 | 7 | d3e6c768b88b7906f3c7fdd00ba20842212c14b1 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.49e-06 | 177 | 159 | 7 | f8f101c772c043636bedd6b2ec81409b1d2599bf | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.49e-06 | 177 | 159 | 7 | 84116796ca4c7007508c0f1a68a1135c7b922278 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.49e-06 | 177 | 159 | 7 | 2f81b26be89cc2fd8eafadaf7eae3c6ad6521462 | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-NK_activated|COVID-19_Mild / Disease group, lineage and cell class | 3.49e-06 | 177 | 159 | 7 | 6978a22fef40c8b455342373abe7593f5ede0fa4 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.49e-06 | 177 | 159 | 7 | 936ab2b180a052387124f68d0c7f41c0b164e748 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.49e-06 | 177 | 159 | 7 | d5aeda113afaa2425874394610344570c9078478 | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.20e-06 | 182 | 159 | 7 | b4fc5e4f5d8440a3c9ee0a6fd0da87b43cabc8c6 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.20e-06 | 182 | 159 | 7 | 4a9c13932e7163fd37a3dcc4c6ca3bbea5372459 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.35e-06 | 183 | 159 | 7 | 85446581999cd66b171c4f69b7eb8b0bbbaa8617 | |
| ToppCell | wk_08-11-Epithelial-PNS-PCP4+_neuron|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.51e-06 | 184 | 159 | 7 | eac2a9089913f33a961ba11519b53645790f2056 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.51e-06 | 184 | 159 | 7 | 9434731f651820b05335085582960f08fbf895de | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.67e-06 | 185 | 159 | 7 | 08fad1e3c3cc5f1c3eb6629a49c094b628e75a92 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.67e-06 | 185 | 159 | 7 | 0b5a0df58ae2ad8261f40f152775747af4f3937a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.84e-06 | 186 | 159 | 7 | a417e1e21313a7e05951038cdef5ac672a9f727c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.84e-06 | 186 | 159 | 7 | 7278a1a1bf9bb27aeb03852134defb31b62f30d6 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.19e-06 | 188 | 159 | 7 | ee572246e0c2f41bdbc29a03edc67b831af95c09 | |
| ToppCell | droplet-Spleen-nan-21m-Lymphocytic-plasma_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.19e-06 | 188 | 159 | 7 | 70184b14160b71a1fecd7f195e5a16c5937738a2 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_postreplicative-neuro_immature_neuronal_(2)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.38e-06 | 189 | 159 | 7 | de06ef69f3f97b3f21dc269eb6965da9b2f6e3f8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.38e-06 | 189 | 159 | 7 | 55420853f730b433ef58ac9337ac84ac78a247a0 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Epcam____thick_ascending_tube_S_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.57e-06 | 190 | 159 | 7 | c247562df3e1aa3173c9f01a74d5831f0764a1b2 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.57e-06 | 190 | 159 | 7 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.57e-06 | 190 | 159 | 7 | 5cea8298c8336c136ba009630c9e48d4bc832cb2 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.96e-06 | 192 | 159 | 7 | f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 5.96e-06 | 192 | 159 | 7 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.17e-06 | 193 | 159 | 7 | 9f9eb241b0b82a6f12de6921c3acf6fed7cf65bb | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Epcam_____kidney_distal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.17e-06 | 193 | 159 | 7 | b397c14ac1e34c6be3f25d4417d200bc518d3048 | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Lymphocytic-plasma_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.60e-06 | 195 | 159 | 7 | f9a90cd7b4e99a0947fdb3645f7787d02b0f7ca0 | |
| ToppCell | Control-Lymphoid-T|Lymphoid / Disease state, Lineage and Cell class | 6.60e-06 | 195 | 159 | 7 | 6687e579582d7a239bee80846de0cf827a6f6a62 | |
| ToppCell | severe-Plasmablast|severe / disease stage, cell group and cell class | 6.60e-06 | 195 | 159 | 7 | e11616ad568e50e4c720b50b0c071f484c31d16b | |
| ToppCell | COPD-Lymphoid-T|COPD / Disease state, Lineage and Cell class | 6.82e-06 | 196 | 159 | 7 | 30e53b8050d2a041f855d0e39bbd8f923c64c489 | |
| ToppCell | COVID_vent-Lymphocytic-Plasma_cell-IgA_Plasmablast|COVID_vent / Disease condition, Lineage, Cell class and subclass | 7.05e-06 | 197 | 159 | 7 | 99fe44ef42c65d24fe64947fd5bf6d91b9a4b2c3 | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 7.05e-06 | 197 | 159 | 7 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-LGR5--L5-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 7.78e-06 | 200 | 159 | 7 | 8c1d4fffa5abe89ee2ff84fed2dfa97c779bde04 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-LGR5-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 7.78e-06 | 200 | 159 | 7 | 1026b4ede4ea61d01ea942164b37a08c8c8234ff | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 7.78e-06 | 200 | 159 | 7 | d0167f96314be78b6d867bbcc6e4396071d931b8 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CHRM2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 7.78e-06 | 200 | 159 | 7 | 501a3b93624df463458a35d3e6648d4ccc941724 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CHRM2-L1-3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 7.78e-06 | 200 | 159 | 7 | d1f36a8232411933b1494168ec912fd0e5246428 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-LGR5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 7.78e-06 | 200 | 159 | 7 | 72c9cd872074b60f62685a95eab83c41e609eb6e | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Gpc3_Slc18a3|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.94e-06 | 137 | 159 | 6 | d346086f42d8f04d3fa67fe696834284acdc7080 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Endocervical_Adenocarcinoma-Mucinous_Adenocarcinoma-4|TCGA-Cervix / Sample_Type by Project: Shred V9 | 1.22e-05 | 142 | 159 | 6 | 369f2e51e0283a4de70e6c7a3b95672c0838f205 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lmo1_Myl1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.37e-05 | 145 | 159 | 6 | 590ba937c741ae67460f303eca88b1cd3ac87f64 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.54e-05 | 148 | 159 | 6 | 5e738522d4ad35e08bc4ff8c41b7bea38ec6ef95 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lmo1_Fam159b|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.60e-05 | 149 | 159 | 6 | 98ae408d2d0347865875ff8bbd89d359decea526 | |
| ToppCell | frontal_cortex|World / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.80e-05 | 152 | 159 | 6 | f9c29d4568402ca07a717dbffb3ccc7f35c5fe56 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.01e-05 | 155 | 159 | 6 | 77fdae85d36efb776db977eb424b32487ef222e4 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Lypd1_Gpr88|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.16e-05 | 157 | 159 | 6 | 5aee90ad7aaa65fdabc23597451da5e48db8f4e6 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Gpc3_Slc18a3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.66e-05 | 163 | 159 | 6 | ec9a20cfe0d69430f9c68cddd1ab0e4a3e4554b8 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Crispld2_Htr2c|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.85e-05 | 165 | 159 | 6 | c6b23013d77fa9aa967b76e451c8e42b0a657c30 | |
| ToppCell | droplet-Thymus-nan-21m-Myeloid-Plasma_cells_and_B_cells|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-05 | 165 | 159 | 6 | 21a82a975f550080b6674750b06212205cd16742 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.05e-05 | 167 | 159 | 6 | 25af48c640e67848594f5902867ba325fc105da4 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.26e-05 | 169 | 159 | 6 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | COVID-19_Severe-Treg|COVID-19_Severe / disease group, cell group and cell class | 3.37e-05 | 170 | 159 | 6 | d61269a51283125835884c4aa50623756c4fdda2 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Ptprt_Pkp2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.37e-05 | 170 | 159 | 6 | 14aa86a4f526ed6986afcb28c49225522055550c | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.48e-05 | 171 | 159 | 6 | 4ede831aed364cb5271f49a8b09bb6d0452f9b35 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-6_VIP_RGS16|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.60e-05 | 172 | 159 | 6 | 8b396d1e9173da104d467e42286379fe07cee257 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.60e-05 | 172 | 159 | 6 | 7e1a7700a4c2b1d100da1d6e475e73498ebb605a | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.72e-05 | 173 | 159 | 6 | bba8265a58f8f5659dc7b9da2fe27b15033fce34 | |
| ToppCell | LPS-IL1RA-Lymphocytic_NKT-iNKT/MAIT-iNKT-MAIT|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.72e-05 | 173 | 159 | 6 | fde1fabb8d13d05998ac3f21ecb1fde6a7a2f337 | |
| ToppCell | droplet-Kidney-nan-18m-Lymphocytic-CD45____plasma_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.72e-05 | 173 | 159 | 6 | 60e427f6c7d953cef5f692043670ff0b49cdce72 | |
| ToppCell | LV-17._Lymphocyte|World / Chamber and Cluster_Paper | 3.72e-05 | 173 | 159 | 6 | 212f013ff761cbab24a537071739867c08c402a4 | |
| ToppCell | LPS-IL1RA-Lymphocytic_NKT-iNKT/MAIT|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.72e-05 | 173 | 159 | 6 | dcde3252ff96448d3a61039a4948c74ad321a218 | |
| ToppCell | droplet-Kidney-nan-18m-Lymphocytic-plasma_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.84e-05 | 174 | 159 | 6 | c92eec5a14ca5269673582dd115ead8516e64c3e | |
| ToppCell | Healthy_Control-Myeloid-Mast|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 3.96e-05 | 175 | 159 | 6 | ca187074adcc9b8bd0fa270e2ede1564c8e6c6cf | |
| ToppCell | Healthy_Control-Myeloid-Mast-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 3.96e-05 | 175 | 159 | 6 | eadbbcdf2aef4cee268bc70a7a2c4175d898953b | |
| ToppCell | COVID-19-lung-B_cells|lung / Disease (COVID-19 only), tissue and cell type | 4.22e-05 | 177 | 159 | 6 | f54691e5558091c1734ab15153a10bff15ed171e | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP-neuro_pre_proliferating_SCP_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.22e-05 | 177 | 159 | 6 | 59726bfd98f656fdcedf448a7e2e76a9bfad8285 | |
| ToppCell | droplet-Spleen-SPLEEN-1m-Lymphocytic-plasma_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.36e-05 | 178 | 159 | 6 | b902059c3f861108fc64cbdc05e6f44378f5be2c | |
| Computational | Neighborhood of ERCC4 | CACNA1C ABO HTR3A DNAJC16 GRIK1 SIM2 SLC6A2 SCN7A CCR3 MAGEC1 SLC33A1 | 1.63e-05 | 321 | 77 | 11 | MORF_ERCC4 |
| Computational | Neighborhood of NOS2A | 2.05e-04 | 288 | 77 | 9 | MORF_NOS2A | |
| Computational | Neighborhood of CAMK4 | 2.16e-04 | 290 | 77 | 9 | MORF_CAMK4 | |
| Computational | Neighborhood of ARL3 | 3.07e-04 | 304 | 77 | 9 | MORF_ARL3 | |
| Computational | Neighborhood of BCL2L11 | 3.59e-04 | 186 | 77 | 7 | MORF_BCL2L11 | |
| Computational | Neighborhood of RAD51L3 | ABO HTR3A DNAJC16 GRIK1 SIM2 SLC6A2 SCN7A CCR3 ATP2B2 SLC33A1 | 4.15e-04 | 387 | 77 | 10 | MORF_RAD51L3 |
| Computational | Neighborhood of MAGEA8 | 5.23e-04 | 260 | 77 | 8 | MORF_MAGEA8 | |
| Computational | Neighborhood of SUPT3H | 5.34e-04 | 328 | 77 | 9 | MORF_SUPT3H | |
| Computational | Neighborhood of ATF2 | 5.58e-04 | 330 | 77 | 9 | MORF_ATF2 | |
| Computational | Neighborhood of FOSL1 | ABO HTR3A DNAJC16 GRIK1 SIM2 SLC6A2 SCN7A CCR3 ATP2B2 SLC33A1 | 6.04e-04 | 406 | 77 | 10 | MORF_FOSL1 |
| Computational | Neighborhood of MAGEA9 | ABO HTR3A DNAJC16 GRIK1 SIM2 SLC6A2 SCN7A CCR3 ATP2B2 SLC33A1 | 8.29e-04 | 423 | 77 | 10 | MORF_MAGEA9 |
| Computational | Neighborhood of MDM2 | 8.31e-04 | 279 | 77 | 8 | MORF_MDM2 | |
| Computational | Neighborhood of FSHR | 8.31e-04 | 279 | 77 | 8 | MORF_FSHR | |
| Computational | Membranal receptors. | HTR3A GRIK1 SLC6A2 CD247 FCGR3A SLC22A4 HPS1 SCN7A CCR1 C3 HAS2 | 1.07e-03 | 517 | 77 | 11 | MODULE_64 |
| Computational | Neighborhood of TNFRSF6 | 1.23e-03 | 167 | 77 | 6 | MORF_TNFRSF6 | |
| Computational | Neighborhood of MLLT10 | 1.38e-03 | 302 | 77 | 8 | MORF_MLLT10 | |
| Computational | Ion channels. | 1.56e-03 | 70 | 77 | 4 | MODULE_316 | |
| Computational | Neighborhood of MYL3 | 1.56e-03 | 70 | 77 | 4 | MORF_MYL3 | |
| Computational | Neighborhood of IL16 | 1.58e-03 | 239 | 77 | 7 | MORF_IL16 | |
| Computational | Neighborhood of PTPRB | 2.23e-03 | 254 | 77 | 7 | MORF_PTPRB | |
| Computational | Genes in the cancer module 288. | 2.31e-03 | 37 | 77 | 3 | MODULE_288 | |
| Computational | Whole blood genes. | TRIB2 HTR3A SLC7A7 SLC6A2 ACSL1 CD247 FCGR3A FCGR3B HPS1 CCR1 CCR3 | 2.71e-03 | 581 | 77 | 11 | MODULE_45 |
| Computational | Vesicular transport / synapse genes. | 2.79e-03 | 82 | 77 | 4 | MODULE_274 | |
| Computational | Neighborhood of CDH4 | 2.87e-03 | 136 | 77 | 5 | MORF_CDH4 | |
| Computational | Neighborhood of IFNA1 | 3.44e-03 | 205 | 77 | 6 | MORF_IFNA1 | |
| Computational | Genes in the cancer module 119. | 3.56e-03 | 143 | 77 | 5 | MODULE_119 | |
| Drug | potassium | SLC12A6 CACNA1C GPR89B CACNA1D CACNA1F CACNA1S PDE3B HTR3A SLC24A3 GRIK1 SLC7A7 CHRM2 SLC1A4 RYR2 SLC5A1 TPCN1 ITPR3 SLC5A11 ACSL1 KCNQ5 SCN2A SCN3A SCN7A KCNK10 KCNK2 SLC9A7 C3 ATP12A SLC12A7 ATP2B2 SLC33A1 ATP2B4 | 3.44e-13 | 1008 | 157 | 32 | CID000000813 |
| Drug | lamotrigine | CACNA1C CACNA1D CACNA1F CACNA1S GRIK1 RYR2 TPCN1 ITPR3 SCN2A SCN3A SCN7A | 4.97e-10 | 116 | 157 | 11 | CID000003878 |
| Drug | pimozide | CACNA1C CACNA1D CACNA1F CACNA1S TRPC7 HTR3A CHRM2 RYR2 TPCN1 ITPR3 VPS13A | 1.32e-09 | 127 | 157 | 11 | CID000016362 |
| Drug | sodium | SLC12A6 CACNA1C GPR89B CACNA1D CACNA1S SPNS1 SLC5A10 SLC24A3 GRIK1 SLC7A7 SLC1A4 RYR2 SLC5A1 TPCN1 SLC5A11 SLC6A2 SCN2A SLC22A4 SCN3A SCN7A KCNK2 SLC9A7 SLC5A8 ATP12A ATP2B2 ATP2B4 | 1.58e-09 | 944 | 157 | 26 | CID000000923 |
| Drug | gabapentin | CACNA1C CACNA1D CACNA1F CACNA1S HTR3A GRIK1 RYR2 TPCN1 ITPR3 SLC5A11 SCN3A SCN7A | 2.27e-09 | 169 | 157 | 12 | CID000003446 |
| Drug | riluzole | CACNA1C CACNA1D CACNA1F CACNA1S GRIK1 GRIK2 RYR2 ITPR3 SCN3A SCN7A KCNK10 KCNK2 | 3.16e-09 | 174 | 157 | 12 | CID000005070 |
| Drug | Cinildipine | 4.58e-09 | 56 | 157 | 8 | CID000002752 | |
| Drug | halothane | CACNA1C CACNA1D CACNA1F CACNA1S GRIK1 CHRM2 RYR2 TPCN1 ITPR3 GJD3 KCNK10 KCNK2 CYP7B1 ATP2B2 ATP2B4 | 5.09e-09 | 314 | 157 | 15 | CID000003562 |
| Drug | Bay K 8644 | CACNA1C CACNA1D CACNA1F CACNA1S CHRM2 RYR2 TPCN1 ITPR3 HPS1 ATP2B2 ATP2B4 | 7.70e-09 | 150 | 157 | 11 | CID000002303 |
| Drug | procaine | CACNA1C CACNA1D CACNA1F CACNA1S HTR3A CHRM2 RYR2 TPCN1 ITPR3 SCN3A SCN7A | 9.48e-09 | 153 | 157 | 11 | CID000004914 |
| Drug | bepridil | CACNA1C CACNA1D CACNA1F CACNA1S RYR2 TPCN1 ITPR3 SCN3A SCN7A ATP2B2 | 1.77e-08 | 126 | 157 | 10 | CID000002351 |
| Drug | AC1L2AC7 | 2.50e-08 | 69 | 157 | 8 | CID000068733 | |
| Drug | isradipine | CACNA1C CACNA1D CACNA1F CACNA1S RYR2 TPCN1 ITPR3 SCN3A SCN7A | 3.12e-08 | 100 | 157 | 9 | CID000003784 |
| Drug | loperamide | CACNA1C CACNA1D CACNA1F CACNA1S HTR3A RYR2 SLC5A1 TPCN1 ITPR3 | 4.78e-08 | 105 | 157 | 9 | CID000003954 |
| Drug | verapamil | CACNA1C CACNA1D CACNA1F CACNA1S CHRM2 RYR2 TPCN1 ITPR3 ABCG1 KCNQ5 SLC22A4 SCN3A SCN7A KCNK10 ABCD3 ATP2B2 ATP2B4 | 5.31e-08 | 490 | 157 | 17 | CID000002520 |
| Drug | NSC7524 | CACNA1C CACNA1D CACNA1F CACNA1S GRIK1 CHRM2 RYR2 ITPR3 SCN2A SCN3A SCN7A | 5.72e-08 | 182 | 157 | 11 | CID000005657 |
| Drug | nisoldipine | 6.66e-08 | 78 | 157 | 8 | CID000004499 | |
| Drug | nimodipine | CACNA1C CACNA1D CACNA1F CACNA1S GRIK1 RYR2 TPCN1 ITPR3 ATP2B2 ATP2B4 | 6.77e-08 | 145 | 157 | 10 | CID000004497 |
| Drug | CNS 1145 | 9.28e-08 | 33 | 157 | 6 | CID000190902 | |
| Drug | IHC-64 | 9.28e-08 | 33 | 157 | 6 | CID000162753 | |
| Drug | dihydropyridine | CACNA1C CACNA1D CACNA1F CACNA1S CHRM2 RYR2 TPCN1 ITPR3 HPS1 ATP2B2 ATP2B4 | 1.04e-07 | 193 | 157 | 11 | CID000104822 |
| Drug | nilvadipine | 1.84e-07 | 60 | 157 | 7 | CID000004494 | |
| Drug | lercanidipine | 2.59e-07 | 63 | 157 | 7 | CID000065866 | |
| Drug | Cinnarizine | 2.67e-07 | 9 | 157 | 4 | DB00568 | |
| Drug | Nimodipine | 2.67e-07 | 9 | 157 | 4 | DB00393 | |
| Drug | felodipine | CACNA1C CACNA1D CACNA1F CACNA1S PDE3B RYR2 TPCN1 ITPR3 CYP7B1 SLC33A1 | 2.85e-07 | 169 | 157 | 10 | CID000003333 |
| Drug | manidipine | 3.13e-07 | 95 | 157 | 8 | CID000004008 | |
| Drug | nitrendipine | 3.98e-07 | 98 | 157 | 8 | CID000004507 | |
| Drug | gallopamil | 3.98e-07 | 67 | 157 | 7 | CID000001234 | |
| Drug | indo-1 | 4.30e-07 | 99 | 157 | 8 | CID000105060 | |
| Drug | lanthanum | CACNA1C CACNA1D CACNA1F CACNA1S RYR2 TPCN1 ITPR3 ATP2B2 ATP2B4 | 4.44e-07 | 136 | 157 | 9 | CID000023926 |
| Drug | Mibefradil | 6.92e-07 | 11 | 157 | 4 | DB01388 | |
| Drug | CAS 298-57-7 | 7.21e-07 | 73 | 157 | 7 | CID000002761 | |
| Drug | Dantrolene-13C3 | 7.64e-07 | 145 | 157 | 9 | CID000002951 | |
| Drug | ethosuximide | 7.92e-07 | 74 | 157 | 7 | CID000003291 | |
| Drug | KB-R7943 | 8.30e-07 | 47 | 157 | 6 | CID004534086 | |
| Drug | AC1L1KC5 | CACNA1C CACNA1D CACNA1F CACNA1S ERBB4 TRPC7 GRIK1 CHRM2 RYR2 TPCN1 ITPR3 MBTPS2 NISCH TRPV3 ATP2B2 ATP2B4 | 1.12e-06 | 541 | 157 | 16 | CID000005428 |
| Drug | gadolinium | CACNA1C CACNA1D CACNA1F CACNA1S RYR2 ITPR3 KCNK10 KCNK2 TRPV3 SLC33A1 | 1.28e-06 | 199 | 157 | 10 | CID000023982 |
| Drug | AC1NBU2S | 1.54e-06 | 117 | 157 | 8 | CID004473765 | |
| Drug | caffeine | CACNA1C CACNA1D CACNA1F CACNA1S PDE3B RPN1 GRIK1 GRIK2 CHRM2 RYR2 TPCN1 ITPR3 HPS1 CYP7B1 ATP2B2 ATP2B4 | 1.83e-06 | 562 | 157 | 16 | CID000002519 |
| Drug | XeC compound | 1.88e-06 | 84 | 157 | 7 | CID000005701 | |
| Drug | Sodium | 1.88e-06 | 84 | 157 | 7 | ctd:D012964 | |
| Drug | fluo-3 | 2.12e-06 | 122 | 157 | 8 | CID000104978 | |
| Drug | FPL 64176 | 2.80e-06 | 15 | 157 | 4 | CID000003423 | |
| Drug | lavendustin A | CACNA1C CACNA1D CACNA1F CACNA1S ERBB4 HTR3A RASGRF1 RYR2 ITPR3 | 3.01e-06 | 171 | 157 | 9 | CID000003894 |
| Drug | phenytoin | CACNA1C CACNA1D CACNA1F CACNA1S RYR2 TPCN1 ITPR3 SCN2A SCN3A SCN7A | 3.02e-06 | 219 | 157 | 10 | CID000001775 |
| Drug | Nisoldipine | 3.18e-06 | 5 | 157 | 3 | DB00401 | |
| Drug | Nilvadipine | 3.18e-06 | 5 | 157 | 3 | DB06712 | |
| Drug | Verapamil | 3.71e-06 | 16 | 157 | 4 | DB00661 | |
| Drug | isoflurane | CACNA1C CACNA1S GRIK1 GRIK2 CHRM2 SCN3A SCN7A KCNK10 KCNK2 ATP2B2 ATP2B4 | 3.96e-06 | 279 | 157 | 11 | CID000003763 |
| Drug | IAA-94 | 3.97e-06 | 61 | 157 | 6 | CID000003667 | |
| Drug | Diltiazem | 4.02e-06 | 35 | 157 | 5 | ctd:D004110 | |
| Drug | methylglucamine | 4.37e-06 | 62 | 157 | 6 | CID000004049 | |
| Drug | Zonisamide | 4.83e-06 | 17 | 157 | 4 | DB00909 | |
| Drug | mag-fura-2 | 5.33e-06 | 37 | 157 | 5 | CID000123839 | |
| Drug | APETx1, Anthopleura elegantissima | 6.34e-06 | 6 | 157 | 3 | ctd:C475726 | |
| Drug | CPU-23 | 6.34e-06 | 6 | 157 | 3 | CID003036051 | |
| Drug | baclofen | CACNA1C CACNA1D CACNA1F CACNA1S HTR3A GRIK1 RYR2 ITPR3 GABBR1 | 7.41e-06 | 191 | 157 | 9 | CID000002284 |
| Drug | AC1L1DXE | CACNA1C CACNA1D CACNA1F CACNA1S TRPC7 HTR3A GRIK1 CHRM2 RYR2 ITPR3 TRPV3 | 7.64e-06 | 299 | 157 | 11 | CID000002548 |
| Drug | nicardipine | 7.66e-06 | 145 | 157 | 8 | CID000004473 | |
| Drug | pyraclofos | 8.92e-06 | 106 | 157 | 7 | CID000093460 | |
| Drug | tetradotoxin | CACNA1C CACNA1D SCN11A HTR3A GRIK1 GRIK2 CHRM2 SCN2A SCN3A SCN7A SCN8A TRPV3 HTR3B | 8.95e-06 | 428 | 157 | 13 | CID000020382 |
| Drug | pseudococaine | SCN11A HTR3A CD164 GRIK1 GRIK2 CHRM2 SLC6A2 SCN3A SCN7A CCR1 CCR3 HTR3B HAS2 ATP2B2 ATP2B4 | 1.00e-05 | 570 | 157 | 15 | CID000002826 |
| Drug | 8-bromoguanosine 3',5'-cyclic monophosphate | SLC12A6 CACNA1C CACNA1D CACNA1F CACNA1S GRIK1 CHRM2 RYR2 ITPR3 KCNK10 SLC12A7 | 1.01e-05 | 308 | 157 | 11 | CID000001915 |
| Drug | Amlodipine | 1.10e-05 | 7 | 157 | 3 | DB00381 | |
| Drug | Isradipine | 1.10e-05 | 7 | 157 | 3 | DB00270 | |
| Drug | myo-inositol | CACNA1C CACNA1D CACNA1F CACNA1S ERBB4 PDE3B GRIK1 CHRM2 RYR2 SLC5A1 ITPR3 SLC5A11 FCGR3A FCGR3B NISCH PPIP5K2 ATP2B2 ATP2B4 | 1.30e-05 | 811 | 157 | 18 | CID000000892 |
| Drug | Intravenous Immunoglobulin | 1.76e-05 | 8 | 157 | 3 | DB00028 | |
| Drug | Nifedipine | 1.76e-05 | 8 | 157 | 3 | DB01115 | |
| Drug | Cocaine | 1.76e-05 | 8 | 157 | 3 | DB00907 | |
| Drug | 2,3,5,6-tetrafluoro-4-methylbenzyl (Z)-(1RS)-cis-3-(2-chloro-3,3,3-trifluoroprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate | 1.76e-05 | 8 | 157 | 3 | ctd:C489827 | |
| Drug | Nitrendipine | 1.76e-05 | 8 | 157 | 3 | DB01054 | |
| Drug | N-cyclopentyl-N-cyclobutylformamide | 1.79e-05 | 79 | 157 | 6 | CID005287890 | |
| Drug | AC1L1KS5 | CACNA1C CACNA1D CACNA1F CACNA1S CHRM2 RYR2 ITPR3 KCNK10 CCR6 ATP2B2 ATP2B4 | 2.14e-05 | 334 | 157 | 11 | CID000005631 |
| Drug | quindine | 2.21e-05 | 219 | 157 | 9 | CID000001065 | |
| Drug | gamma-aminobutyric acid | CACNA1C CACNA1D CACNA1F CACNA1S ERBB4 HTR3A GRIK1 GRIK2 CHRM2 RYR2 ITPR3 VPS13A GABBR1 | 2.62e-05 | 474 | 157 | 13 | CID000000119 |
| Drug | TMB-8 | 3.12e-05 | 176 | 157 | 8 | CID000005494 | |
| Drug | nifedipine | CACNA1C CACNA1D CACNA1F CACNA1S GRIK1 CHRM2 RYR2 TPCN1 ITPR3 CYP7B1 ATP2B2 ATP2B4 | 3.24e-05 | 415 | 157 | 12 | CID000004485 |
| Drug | fluperlapine | 3.37e-05 | 27 | 157 | 4 | CID000049381 | |
| Drug | sodiosodium | 3.52e-05 | 54 | 157 | 5 | CID000141233 | |
| Drug | 3-(1H-pyrrole-2-carboxylate | CACNA1C CACNA1D CACNA1S SLC24A3 CHRM2 RYR2 ITPR3 ATP2B2 ATP2B4 | 3.59e-05 | 233 | 157 | 9 | CID000005114 |
| Drug | AC1L3TPS | 3.73e-05 | 10 | 157 | 3 | CID000121952 | |
| Drug | D-myo-inositol-1,4,5-triphosphate | CACNA1C CACNA1D CACNA1F CACNA1S ERBB4 TRPC7 GRIK1 CHRM2 RYR2 TPCN1 ITPR3 ATP2B2 ATP2B4 XPOT | 4.10e-05 | 568 | 157 | 14 | CID000000806 |
| Drug | Hexanols | 4.72e-05 | 2 | 157 | 2 | ctd:D000441 | |
| Drug | Pentanols | 4.72e-05 | 2 | 157 | 2 | ctd:D000439 | |
| Drug | 5-nitro-6,7,8,9-tetrahydrobenzo(G)indole-2,3-dione-3-oxime | 4.72e-05 | 2 | 157 | 2 | ctd:C084273 | |
| Drug | N-methyl-DL-aspartic acid | CACNA1C CACNA1D CACNA1F CACNA1S SPNS1 ERBB4 HTR3A RASGRF1 SLC35B3 GRIK1 GRIK2 CHRM2 RYR2 TPCN1 ITPR3 | 5.00e-05 | 655 | 157 | 15 | CID000004376 |
| Drug | Felodipine | 5.10e-05 | 11 | 157 | 3 | DB01023 | |
| Drug | AC1L201C | 5.10e-05 | 11 | 157 | 3 | CID000012643 | |
| Drug | propofol | 5.58e-05 | 191 | 157 | 8 | CID000004943 | |
| Drug | Flutamide [13311-84-7]; Down 200; 14.4uM; PC3; HT_HG-U133A | 5.58e-05 | 191 | 157 | 8 | 3803_DN | |
| Drug | isotetrandrine | 5.76e-05 | 97 | 157 | 6 | CID000005422 | |
| Drug | Leflunomide [75706-12-6]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 6.22e-05 | 194 | 157 | 8 | 6102_UP | |
| Drug | Foliosidine [2520-38-9]; Down 200; 13uM; MCF7; HT_HG-U133A | 6.69e-05 | 196 | 157 | 8 | 6057_DN | |
| Drug | NSC93767 | 6.73e-05 | 32 | 157 | 4 | CID000005658 | |
| Drug | remifentanil | 6.73e-05 | 32 | 157 | 4 | CID000060814 | |
| Drug | Ro 46861 | 6.76e-05 | 12 | 157 | 3 | CID000003128 | |
| Drug | AMD3451 | 6.76e-05 | 12 | 157 | 3 | CID000503774 | |
| Drug | NA-1 | 6.89e-05 | 62 | 157 | 5 | CID000446091 | |
| Drug | Hydralazine hydrochloride [304-20-1]; Up 200; 20.4uM; MCF7; HT_HG-U133A | 6.93e-05 | 197 | 157 | 8 | 3621_UP | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 3.78e-12 | 10 | 154 | 6 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 3.78e-12 | 10 | 154 | 6 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 1.65e-11 | 12 | 154 | 6 | DOID:0060170 (implicated_via_orthology) | |
| Disease | Timothy syndrome (implicated_via_orthology) | 7.14e-10 | 4 | 154 | 4 | DOID:0060173 (implicated_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | SLC12A6 SCN11A SLC24A3 SLC1A4 SCN1A SCN2A SCN3A SCN7A SCN8A ATP12A SLC12A7 | 1.06e-09 | 163 | 154 | 11 | DOID:1826 (implicated_via_orthology) |
| Disease | Bipolar Disorder | SLC12A6 CACNA1C CACNA1D ERBB4 TRPC7 HTR3A RASGRF1 GRIK1 GRIK2 CHRM2 SLC5A3 SLC6A2 SCN2A SCN8A HTR3B | 3.41e-08 | 477 | 154 | 15 | C0005586 |
| Disease | Duchenne muscular dystrophy (implicated_via_orthology) | 1.20e-06 | 36 | 154 | 5 | DOID:11723 (implicated_via_orthology) | |
| Disease | Mood Disorders | 3.01e-06 | 168 | 154 | 8 | C0525045 | |
| Disease | plexin-B2 measurement | 1.14e-05 | 9 | 154 | 3 | EFO_0021867 | |
| Disease | heart conduction disease (implicated_via_orthology) | 2.29e-05 | 32 | 154 | 4 | DOID:10273 (implicated_via_orthology) | |
| Disease | functional laterality | 2.71e-05 | 2 | 154 | 2 | EFO_0003889 | |
| Disease | level of low affinity immunoglobulin gamma Fc region receptor III-A in blood serum | 2.71e-05 | 2 | 154 | 2 | OBA_2040305 | |
| Disease | Manic Disorder | 3.58e-05 | 71 | 154 | 5 | C0024713 | |
| Disease | Manic | 5.64e-05 | 78 | 154 | 5 | C0338831 | |
| Disease | Depression, Bipolar | 5.99e-05 | 79 | 154 | 5 | C0005587 | |
| Disease | Benign familial infantile epilepsy | 8.09e-05 | 3 | 154 | 2 | cv:C5575231 | |
| Disease | Lupus Vasculitis, Central Nervous System | 8.09e-05 | 3 | 154 | 2 | C0752332 | |
| Disease | Lupus Meningoencephalitis | 8.09e-05 | 3 | 154 | 2 | C0752334 | |
| Disease | Neuropsychiatric Systemic Lupus Erythematosus | 8.09e-05 | 3 | 154 | 2 | C0752335 | |
| Disease | chromosome 15q11.2 deletion syndrome (implicated_via_orthology) | 8.09e-05 | 3 | 154 | 2 | DOID:0060393 (implicated_via_orthology) | |
| Disease | Olmsted syndrome | 8.09e-05 | 3 | 154 | 2 | C2609071 | |
| Disease | Alcoholic Intoxication, Chronic | 8.68e-05 | 268 | 154 | 8 | C0001973 | |
| Disease | Antibody Deficiency Syndrome | 8.98e-05 | 17 | 154 | 3 | C0003257 | |
| Disease | congenital stationary night blindness (is_implicated_in) | 1.61e-04 | 4 | 154 | 2 | DOID:0050534 (is_implicated_in) | |
| Disease | anxiety disorder (implicated_via_orthology) | 2.00e-04 | 22 | 154 | 3 | DOID:2030 (implicated_via_orthology) | |
| Disease | Immunologic Deficiency Syndromes | 2.29e-04 | 23 | 154 | 3 | C0021051 | |
| Disease | Anhedonia | 2.60e-04 | 24 | 154 | 3 | C0178417 | |
| Disease | interleukin-6 measurement | 3.11e-04 | 112 | 154 | 5 | EFO_0004810 | |
| Disease | Bradycardia | 3.32e-04 | 26 | 154 | 3 | C0428977 | |
| Disease | granulocyte count | 3.91e-04 | 254 | 154 | 7 | EFO_0007987 | |
| Disease | Hailey-Hailey disease (implicated_via_orthology) | 4.00e-04 | 6 | 154 | 2 | DOID:0050429 (implicated_via_orthology) | |
| Disease | Familial benign neonatal epilepsy | 4.00e-04 | 6 | 154 | 2 | C0220669 | |
| Disease | heavy drinking | 4.00e-04 | 6 | 154 | 2 | C0687132 | |
| Disease | Seizure, Febrile, Simple | 5.59e-04 | 7 | 154 | 2 | C0149886 | |
| Disease | low affinity immunoglobulin gamma Fc region receptor II-a/b measurement | 5.59e-04 | 7 | 154 | 2 | EFO_0008211 | |
| Disease | Seizure, Febrile, Complex | 5.59e-04 | 7 | 154 | 2 | C0751057 | |
| Disease | alpha 1-antitrypsin deficiency (implicated_via_orthology) | 5.59e-04 | 7 | 154 | 2 | DOID:13372 (implicated_via_orthology) | |
| Disease | colorectal health | 6.75e-04 | 201 | 154 | 6 | EFO_0008460 | |
| Disease | axial length measurement | 7.18e-04 | 77 | 154 | 4 | EFO_0005318 | |
| Disease | Schizophrenia | CACNA1C CACNA1F ERBB4 HTR3A RTN4 GRIK1 GRIK2 CHRM2 SLC6A2 CYFIP1 HTR3B MAGEC1 GABBR1 | 7.67e-04 | 883 | 154 | 13 | C0036341 |
| Disease | glycine measurement | 7.79e-04 | 137 | 154 | 5 | EFO_0009767 | |
| Disease | Graves disease | 8.69e-04 | 81 | 154 | 4 | EFO_0004237 | |
| Disease | hematocrit | CACNA1C TRIB2 ABO DNAJC16 WNT7B SERINC2 SIM2 PGAP6 ITPR3 FCGR3A FCGR3B SLC9A7 TRIB1 RNF182 | 8.72e-04 | 1011 | 154 | 14 | EFO_0004348 |
| Disease | Epilepsy, Cryptogenic | 9.10e-04 | 82 | 154 | 4 | C0086237 | |
| Disease | Awakening Epilepsy | 9.10e-04 | 82 | 154 | 4 | C0751111 | |
| Disease | Aura | 9.10e-04 | 82 | 154 | 4 | C0236018 | |
| Disease | neutrophil count, eosinophil count | 9.13e-04 | 213 | 154 | 6 | EFO_0004833, EFO_0004842 | |
| Disease | Febrile Convulsions | 9.51e-04 | 9 | 154 | 2 | C0009952 | |
| Disease | anterior uveitis (biomarker_via_orthology) | 9.51e-04 | 9 | 154 | 2 | DOID:1407 (biomarker_via_orthology) | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 9.51e-04 | 9 | 154 | 2 | C3502809 | |
| Disease | aspirin use measurement | 1.11e-03 | 39 | 154 | 3 | EFO_0007013 | |
| Disease | neutrophil count, basophil count | 1.18e-03 | 224 | 154 | 6 | EFO_0004833, EFO_0005090 | |
| Disease | diabetes mellitus biomarker | 1.18e-03 | 10 | 154 | 2 | EFO_0006842 | |
| Disease | 2-aminobutyrate measurement | 1.18e-03 | 10 | 154 | 2 | EFO_0020017 | |
| Disease | serum metabolite measurement | ABO RASGRF1 RPN1 DNAJC16 SLC24A3 GRIK2 SLC1A4 PACRGL SLC44A5 SLC22A4 SORCS3 SLC51A TRIB1 | 1.41e-03 | 945 | 154 | 13 | EFO_0005653 |
| Disease | asthma (is_implicated_in) | 1.43e-03 | 157 | 154 | 5 | DOID:2841 (is_implicated_in) | |
| Disease | cocaine use | 1.44e-03 | 11 | 154 | 2 | C3496069 | |
| Disease | campesterol measurement | 1.44e-03 | 11 | 154 | 2 | EFO_0020008 | |
| Disease | Charcot-Marie-Tooth disease (is_implicated_in) | 1.73e-03 | 12 | 154 | 2 | DOID:10595 (is_implicated_in) | |
| Disease | hexanoylcarnitine measurement | 1.73e-03 | 12 | 154 | 2 | EFO_0021040 | |
| Disease | alcoholic pancreatitis | 1.76e-03 | 98 | 154 | 4 | EFO_1002013 | |
| Disease | homostachydrine measurement | 2.03e-03 | 13 | 154 | 2 | EFO_0021164 | |
| Disease | Infantile Severe Myoclonic Epilepsy | 2.03e-03 | 13 | 154 | 2 | C0751122 | |
| Disease | rhinitis (biomarker_via_orthology) | 2.03e-03 | 13 | 154 | 2 | DOID:4483 (biomarker_via_orthology) | |
| Disease | malaria | 2.04e-03 | 102 | 154 | 4 | EFO_0001068 | |
| Disease | platelet component distribution width | CACNA1C SCN11A ABO RPN1 DBF4B CYFIP1 FCGR3B GJD3 SLC12A7 TRIB1 ANKS1A | 2.11e-03 | 755 | 154 | 11 | EFO_0007984 |
| Disease | Mental Depression | 2.23e-03 | 254 | 154 | 6 | C0011570 | |
| Disease | blood copper measurement | 2.28e-03 | 50 | 154 | 3 | EFO_0007578 | |
| Disease | low affinity immunoglobulin gamma Fc region receptor III-B measurement | 2.36e-03 | 14 | 154 | 2 | EFO_0008212 | |
| Disease | glucose-dependent insulinotropic peptide measurement, glucose tolerance test | 2.36e-03 | 14 | 154 | 2 | EFO_0004307, EFO_0008464 | |
| Disease | Epilepsy | 2.60e-03 | 109 | 154 | 4 | C0014544 | |
| Disease | MMR-related febrile seizures | 2.72e-03 | 15 | 154 | 2 | EFO_0006519 | |
| Disease | YKL40 measurement | 2.72e-03 | 15 | 154 | 2 | EFO_0004869 | |
| Disease | Myopia | 2.72e-03 | 15 | 154 | 2 | C0027092 | |
| Disease | testosterone measurement | DOCK3 CACNA1D SPNS1 TRPC7 ABO EML4 SLC24A3 GPR83 KCNQ5 TIMM21 NISCH ATP12A SLC51A ATP2B2 ATP2B4 | 2.83e-03 | 1275 | 154 | 15 | EFO_0004908 |
| Disease | response to tenofovir, creatinine clearance measurement | 2.86e-03 | 112 | 154 | 4 | EFO_0007934, EFO_0009279 | |
| Disease | amino acid measurement | 3.06e-03 | 678 | 154 | 10 | EFO_0005134 | |
| Disease | pneumonia (is_implicated_in) | 3.10e-03 | 16 | 154 | 2 | DOID:552 (is_implicated_in) | |
| Disease | Early infantile epileptic encephalopathy with suppression bursts | 3.10e-03 | 16 | 154 | 2 | C0393706 | |
| Disease | serum gamma-glutamyl transferase measurement | ABO PCNX3 EML4 DNAJC16 PGAP6 RYR2 CYFIP2 FCGR3A FCGR3B SLC9A7 C3 TRIB1 | 3.14e-03 | 914 | 154 | 12 | EFO_0004532 |
| Disease | heart rate response to recovery post exercise | 3.32e-03 | 57 | 154 | 3 | EFO_0009185 | |
| Disease | rheumatoid arthritis (is_implicated_in) | 3.49e-03 | 58 | 154 | 3 | DOID:7148 (is_implicated_in) | |
| Disease | partial epilepsy | 3.50e-03 | 17 | 154 | 2 | EFO_0004263 | |
| Disease | low affinity immunoglobulin gamma Fc region receptor II-a measurement | 3.50e-03 | 17 | 154 | 2 | EFO_0021969 | |
| Disease | graft-versus-host disease (is_implicated_in) | 3.50e-03 | 17 | 154 | 2 | DOID:0081267 (is_implicated_in) | |
| Disease | myeloid white cell count | TRIB2 ABO RPN1 ATP13A1 SLC38A9 EFHC1 FCGR3B SLC22A4 C3 SLC12A7 ATP2B4 TRIB1 | 3.83e-03 | 937 | 154 | 12 | EFO_0007988 |
| Disease | Febrile seizure (within the age range of 3 months to 6 years) | 3.92e-03 | 18 | 154 | 2 | HP_0002373 | |
| Disease | glucose measurement | 3.92e-03 | 380 | 154 | 7 | EFO_0004468 | |
| Disease | pursuit maintenance gain measurement | 4.01e-03 | 123 | 154 | 4 | EFO_0008433 | |
| Disease | Depressive disorder | 4.21e-03 | 289 | 154 | 6 | C0011581 | |
| Disease | CCL2 measurement | 4.36e-03 | 126 | 154 | 4 | EFO_0004749 | |
| Disease | coronary artery disease, plasminogen activator inhibitor 1 measurement | 4.40e-03 | 63 | 154 | 3 | EFO_0001645, EFO_0004792 | |
| Disease | Coronary Arteriosclerosis | 4.81e-03 | 65 | 154 | 3 | C0010054 | |
| Disease | Coronary Artery Disease | 4.81e-03 | 65 | 154 | 3 | C1956346 | |
| Disease | temporal lobe epilepsy (is_marker_for) | 4.83e-03 | 20 | 154 | 2 | DOID:3328 (is_marker_for) | |
| Disease | IgA glomerulonephritis (is_marker_for) | 4.83e-03 | 20 | 154 | 2 | DOID:2986 (is_marker_for) | |
| Disease | birth weight | 5.10e-03 | 399 | 154 | 7 | EFO_0004344 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TQGITDTYKLLFAII | 291 | O00400 | |
| LFILVIVGLTFAVYV | 661 | Q15303 | |
| QKVGISLFFTIVDYV | 1666 | Q9HCE0 | |
| GLFIVLILVGYISVK | 216 | A8MXV6 | |
| IISLLVSIYGSKDLF | 501 | Q9UJX6 | |
| IGLTVFAIKKYVAFL | 116 | P16442 | |
| AKLYLDFIVLGIFFI | 646 | P45844 | |
| ITYIVNKAELSLVFV | 186 | P33121 | |
| IVFKTSVLVGYTVFR | 271 | O95264 | |
| EFVITSLKELGYVTL | 846 | Q9HD20 | |
| LVLSVFVAIGEFIYK | 846 | P39086 | |
| FKITLLLGYSVFLII | 276 | P46098 | |
| IFLSVTLVTYIAFEK | 641 | Q8IZP9 | |
| LLGNILVVITFAFYK | 61 | P51684 | |
| YVVKVFSLAVNLIAI | 1081 | P01024 | |
| SPYKTFEVVFIVLVA | 16 | P08172 | |
| IILSITYKGVKFIDA | 981 | Q92625 | |
| LISIYRDKLFFVSVI | 56 | Q9Y2T2 | |
| ELTVLVLVNTIYFKG | 241 | P01008 | |
| ILVLYFTVDTFVVNK | 411 | Q01814 | |
| YQLIVIFILVFAGEK | 926 | P23634 | |
| SIFNIKGFVDILTYI | 246 | Q8N123 | |
| KYVLSVVLDTINAFF | 1466 | Q14573 | |
| ILTSYVFIFVTVLKI | 216 | Q8NGL3 | |
| IVVFVYLTVENKSLF | 166 | Q68G75 | |
| SLFIALITGAYDTIK | 511 | Q9GZU1 | |
| EYVFLVIFTVETVLK | 131 | O60840 | |
| VIFTVETVLKIVAYG | 136 | O60840 | |
| DFVSEAYLITLGKFI | 151 | Q7L576 | |
| FLLTFYVISQVFEIK | 16 | Q92520 | |
| VLLFLYSVLLTKGIE | 181 | Q9H8M7 | |
| FLFIIGSYTLVLKAV | 226 | Q8NH07 | |
| ILILSIIFIKGTYAS | 1001 | O60732 | |
| VLVLGVQAVIFFLYK | 171 | Q04900 | |
| IIVGLFYETEARKVF | 361 | Q9UBS5 | |
| QIKTALKYTLGFVVI | 136 | Q9NUN5 | |
| SIGILFFIIAVSLKY | 316 | P54707 | |
| FFIIAVSLKYQVLDS | 321 | P54707 | |
| RLSLVVGKEVFYTAL | 171 | Q9Y3R5 | |
| VLIFSSFLVYLVEKD | 276 | Q9NR82 | |
| FLVVVLYLIIGATVF | 66 | O95069 | |
| AVTIFFTIIKLVSYR | 66 | A6NKB5 | |
| VFIALKSVLGFVLYA | 1071 | Q9H6A9 | |
| LGRDKVVSVFYSLVI | 271 | Q8NGJ0 | |
| VIFISYLFIFITILK | 211 | Q96R09 | |
| VILISYTFIFITILK | 211 | Q8NH48 | |
| YTLFQDTGLLEIFKI | 701 | Q13370 | |
| SLLQKFALEVYTFTG | 636 | Q9Y2G8 | |
| LFISIILTFKGYLIS | 251 | Q86VI4 | |
| TFIGVFKLIYLDLSS | 96 | Q8N7C0 | |
| VFVTIPAVIFKYIEG | 246 | P57789 | |
| VLKYVLFLLGTLVIA | 631 | Q9HCN3 | |
| DFILIAVSYTLILKT | 211 | Q8NGJ7 | |
| DFILIAVSYTLILKT | 211 | Q8NGJ6 | |
| LTVFDLTVNLKYTGI | 1326 | Q6IE36 | |
| AELKAVLFVVFLVIY | 21 | Q8NH18 | |
| SYITVLPKGTEFVVF | 1096 | Q9BZ72 | |
| DFVSEAYLLTLGKFI | 151 | Q96F07 | |
| KALLIVAYSFIIVFS | 71 | Q9NYM4 | |
| KVLFTIFLVIYITSL | 26 | Q8NGI8 | |
| TLSVIALIVFIYDEK | 221 | Q9HC58 | |
| IFKVLASFYVILVIL | 311 | Q6P9F7 | |
| QYAFLKITLTLVGLF | 186 | Q86UW1 | |
| TVEAFLKVIAYGLLF | 171 | Q13936 | |
| EVFRFYKLVTLKGLI | 336 | Q9UQ03 | |
| TEKYGLLVFQSLVFI | 656 | Q8IZD9 | |
| GLYSEIFFIILLTID | 116 | P51677 | |
| FDQKLIFTVGYSRVL | 681 | Q8TDB6 | |
| IRGLLITLTKFFYAI | 356 | B7ZAQ6 | |
| IRGLLITLTKFFYAI | 356 | P0CG08 | |
| LEKLEYFFLIVFSIE | 86 | Q13698 | |
| GLYSEIFFIILLTID | 116 | P32246 | |
| IYGVILTALFLRVKF | 41 | P20963 | |
| VIEGFLSKEVSYIVS | 76 | Q8NFT6 | |
| TILLGGVIFTIYKES | 486 | Q92819 | |
| EKTVFVLFYFAVGLL | 186 | Q8N144 | |
| VLLFAVDTGLYFSVK | 216 | O75015 | |
| VFILDYVGTLFFLKN | 146 | O75426 | |
| YVGTLFFLKNALVST | 151 | O75426 | |
| VETFVKYLISLSGAL | 441 | O43462 | |
| VGKSLTILGRTFFIY | 331 | Q5JVL4 | |
| KVAVTDEVTYFVLFL | 601 | Q8NCS7 | |
| DEVTYFVLFLGKLLV | 606 | Q8NCS7 | |
| FTVLLGGKYITFILD | 81 | O75881 | |
| SIIFEITFTTIYGKV | 186 | O75881 | |
| TGKIVYFIASVVVLF | 281 | Q9HC35 | |
| LLITAFISYLGFFTK | 3381 | Q9NYC9 | |
| LVLSVFVAVGEFLYK | 831 | Q13002 | |
| VLLFAVDTGLYFSVK | 216 | P08637 | |
| VLKYLFEVHFGLVTV | 111 | Q92902 | |
| LLIDGKVILALFTYV | 386 | A5D8W1 | |
| VLFAITDAFQKVIYL | 106 | P39059 | |
| LVVFIGVRYVNKFAS | 331 | Q9UHW9 | |
| VFVGVKYVNKLALVF | 266 | Q9Y666 | |
| LSILAIYAGVIKSAF | 286 | Q9Y666 | |
| YVVAFILGTEILGKS | 211 | Q9H015 | |
| FSKFNILGTVSVLYL | 311 | Q8NBW4 | |
| VSYVTDFSLVLLIKG | 16 | Q08AI6 | |
| ILLFYKVSTSSVVEG | 4516 | Q92736 | |
| LEKVEYAFLIIFTVE | 161 | Q01668 | |
| YAFLIIFTVETFLKI | 166 | Q01668 | |
| IFTVETFLKIIAYGL | 171 | Q01668 | |
| QLLLFYFVGSIEIVT | 226 | Q8NGG3 | |
| FLFIIGSYTLVLKAV | 226 | B2RN74 | |
| LLIFYIFTLLGNKTI | 31 | P59922 | |
| YTFVSKEGFRELLLV | 131 | Q8N7B6 | |
| FGFVIISYVLIIRAI | 211 | P34982 | |
| FISYVLIISTILKIA | 216 | Q5JRS4 | |
| FISYVLIVTTILKIA | 216 | P0C629 | |
| VAFIAASYILILKAV | 241 | Q8NH67 | |
| ITFPIDKAVSVFYTV | 276 | Q8NGB2 | |
| ALLSVTISFRIYKGV | 1046 | Q9NQC3 | |
| KSIFTFVLIVEFIIG | 6 | Q9NYV8 | |
| LYIQAFVLVFLLGKV | 46 | Q86TM6 | |
| ITKGGIYVLTLLDTF | 461 | P23975 | |
| RTVTKYVTEAFGLLL | 456 | Q68CJ6 | |
| LLSSIFGKQLVVSYF | 121 | Q96HV5 | |
| VVVTLLGAAASYFKL | 151 | P55808 | |
| LFEYLTLFGIADKIS | 306 | P49590 | |
| VLLGIAFVVYKLFLS | 181 | Q96BY9 | |
| LLKIVTGSLLTFYVV | 31 | Q5T9Z0 | |
| YKILAVVLSIFSVIV | 386 | Q68DH5 | |
| LSVVFVGLAVFLIYK | 1131 | Q9UPU3 | |
| FTVIIYVRLDFSITK | 451 | P04843 | |
| FKKTYIGEIFTQILV | 206 | P35237 | |
| KLIFLDSRVTEVTGY | 241 | Q14190 | |
| TGYFGISFVLALIKI | 306 | Q9H1N7 | |
| FTKLSVDLYSGALFI | 136 | P53794 | |
| EVFLPVFYKLGITST | 101 | Q8N695 | |
| AVLYLFIYIFTKISV | 146 | Q8WWX8 | |
| FTGIYTFESLIKILA | 161 | Q9NY46 | |
| IYLLVSKKVTLGVVF | 201 | Q8N6D2 | |
| IIYVTVFILKGITNR | 6 | Q8NH85 | |
| FISFTPVILYFTKVE | 376 | A4IF30 | |
| VGIYLTFTVGLVFLK | 316 | Q5PT55 | |
| LLLFYFVGSIELVTI | 236 | Q8NGG2 | |
| FTTAIVVLDKLITIY | 681 | Q13972 | |
| FTGIYTFESLIKIIA | 161 | P35498 | |
| FLDIVLYIFKLTSAI | 211 | P28288 | |
| FGVLYVKLGALSSVV | 16 | P56706 | |
| IEVVFVTKFLYSILA | 1156 | Q96RL7 | |
| FTVILDFVYSGKLSL | 76 | Q96BR9 | |
| IVEVILGETKAYVFF | 146 | Q96RU8 | |
| SFYSFLLGSEIKLII | 186 | Q0IIM8 | |
| VFTKISLDLYAGALF | 146 | A0PJK1 | |
| DIIVLVTSLGKYIFA | 286 | P43007 | |
| EVGFKFATKTVIYLL | 106 | Q5U3C3 | |
| ITEIILGETKAYVFF | 116 | Q92519 | |
| IVATYIFIFIGETLL | 381 | Q9H2V7 | |
| IFTYAKVLALIAVIV | 186 | Q9UM01 | |
| VLELLVGYRFVTAIF | 971 | Q9Y2I1 | |
| TFTGIYTFESLIKIL | 161 | Q99250 | |
| TGIYTFESLVKIIAR | 166 | Q9UQD0 | |
| FVVGFQKILTLTYVD | 66 | P08240 | |
| GVLVLNSLLKVYFFV | 36 | A0PJX8 | |
| RDFTYLIVVLFGISI | 106 | Q9BVV7 | |
| VFLTIYGVELFLKVA | 481 | Q9ULQ1 | |
| AQVFALLFVTEYLTK | 106 | O43592 | |
| DVLKFLFVYIVFLLG | 586 | Q8NET8 | |
| LLGIYTFEILVKLFA | 151 | Q01118 | |
| FTGIYIFEALIKILA | 166 | Q9UI33 | |
| ELVITKFLRIFSSVY | 296 | Q5TAH2 | |
| RISLFKYITVVVFEE | 66 | O43314 | |
| FVYVFVLGILFTGTK | 761 | Q5H8A4 | |
| TLLVNVSGKFFEYTL | 141 | Q96T83 | |
| LLYIFTKISADIFSG | 151 | P13866 | |
| KFLILVGLTVGAFYI | 136 | Q96SA4 | |
| SIFGLSEVISVVLKY | 626 | Q9HCX4 | |
| TLTGEVNFLKYLFLT | 291 | Q7Z794 |